Refolding studies on 2-oxoacid dehydrogenase multienzyme complexes by Beaumont, Ellen Sarah
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
REFOLDING STUDIES ON 2-OXOACID 
DEHYDROGENASE MULTIENZYME COMPLEXES
Ellen Sarah Beaumont
Thesis submitted to the University of Glasgow for the degree of Doctor of Philosophy 
Division of Biochemistry, IBLS. October 1996
ProQuest N um ber: 10391355
All rights re serv e d
INFORMATION TO ALL USERS 
The q u a lity  of this re p r o d u ctio n  is d e p e n d e n t  u p o n  the q u a lity  of the c o p y  su b m itted .
In the unlikely e v e n t  that the a u th o r  did not sen d  a c o m p le t e  m a n u scrip t  
and there are m issing p a g e s ,  th e se  will be n o te d . A lso, if m ater ia l had to be r e m o v e d ,
a n o t e  will in d ic a te  the d e le t io n .
uest
P ro Q u est 10391355
Published by ProQ uest LLC (2017). C o p y rig h t of the Dissertation is held by the A uthor.
All rights reserv ed .
This work is p ro te c te d  a g a in s t  u n a u th o r ized  c o p y in g  under Title 17, United S ta tes  C o d e
M icroform  Edition ©  ProQ uest LLC.
ProQ uest LLC.
7 89  E ast E isenhow er Parkw ay  
P.Q. Box 1346  
Ann Arbor, Ml 4 8 1 0 6 -  1346
GLASGOW HJNWEKITT
CONTENTS
Page
Abstract
Acknowledgements iv
Abréviations
Table of contents vü
List of figures xi
List of tables xiii
Abstract
The 2-oxoacid dehydrogenase multienzyme complexes are high Mr assemblies 
occupying key positions in intermediary metabolism. Their function is to catalyse the 
irreversible oxidative decarboxylation of 2-oxoacids by the coordinated action of 
multiple copies of three separate enzymes termed El (2-oxoacid dehydrogenase), E2 
(dihydrolipoamide acyl transferase) and E3 (dihydrolipoamide dehydrogenase). The 2- 
oxoacid dehydrogenase multienzyme complex family consists of the pyruvate 
dehydrogenase complex (PDC), 2-oxoglutarate dehydrogenase complex (OGDC) and 
branched chain 2-oxoacid dehydrogenase complex (BCDC). These complexes have 
been purified from a wide variety of organisms and in all complexes studied, the E2 
component forms a symmetrical structural core to which the El and E3 subunits bind. 
The E l and E2 components perform complex specific reaction steps, while the E3 
component is responsible for the reoxidation of the lipoamide group in each of the 
complexes.
In eukaryotes, these nuclear encoded complexes are located in the 
mitochondrion, loosely associated with the inner face of the inner membrane. The in 
vivo translocation, folding and assembly of such large structures is an intriguing 
process which is at present not fully understood.
This thesis examines the GdnHCl-induced deactivation and subsequent 
reactivation on dilution from dénaturant of OGDC and PDC from bovine heart and 
PDC from E. coli. Activity is found to be lost at relatively low GdnHCl 
concentrations in each complex (below 0.3 M). The E. coli PDC is shown to have 
spontaneous reactivation after higher concentrations of GdnHCl incubation than the 
bovine heart complexes. The deactivation and reactivation of the individual complex 
components has also been studied. The E2 component was found to reactivate after 
higher concentration GdnHCl incubations than the peripheral subunits. The 
deactivation and reactivation curves of complex intact and isolated components have 
been compared. For E. coli E3 this revealed a marked difference, with the intact E3
11
being considerably more stable than its isolated counterpart. This effect is thought to 
be due to the hydrophobic association of the E3 dimer with the E2 core, which has 
been shown to be reactivated after higher GdnHCl incubations.
The refolding environment of the E3 component has been studied in more detail 
in Chapter 5. E3 is a member of flavin-containing pyridine nucleotide-disulphide 
oxidoreductases. All members of this group studied to date are homodimers 
containing one flavin adenine dinucleotide (FAD) per subunit and a redox active 
disulphide. Purified E3 from bovine heart, yeast and E, coli have been unfolded using 
GdnHCl (as determined by CD spectra) and refolding has been attempted under a 
variety of conditions. The attempts to refold yeast and bovine E3 from a completely 
unfolded state have proved unsuccessful. The addition of the molecular chaperones 
groEL and groES (and ATP) to the refolding buffer of E. coli E3 gave a 15% 
recovery of activity, compared to no recovery when the protein was diluted into 
buffer alone. The effects of protein concentration and oxidation state of the refolding 
buffer have also been investigated. The single most important factor, however, has 
been found to be inclusion of FAD in the refolding buffer. A 5Told molar excess of 
FAD (compared to E3 monomers) in the refolding buffer gave a 22% recovery of 
activity. It is thought that the FAD is creating a folding nucléation site on the E3 
protein which encourages the protein down the correct folding pathway towards the 
native state.
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CHAPTER 1
INTRODUCTION
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1.12-OXOACID DEHYDROGENASE MULTIENZYME COMPLEXES
1.1.1 Three principal systems
The 2-oxoacid dehydrogenase complexes represent classical examples of 
multienzyme complexes. The pyruvate dehydrogenase complex (PDC), 2-oxoglutarate i
dehydrogenase complex (OGDC) and branched chain 2-oxoacid dehydrogenase 
complex (BCDC) are all members of the thiamine pyrophosphate-requiring 2-oxoacid 
dehydrogenase complex family. As our understanding of macromolecular assembly and |
organisation of protein structure and function stands to benefit directly from a deeper
knowledge of these complexes and because of the key positions in metabolism they
occupy (see Figure 1.1), they have been studied in detail from numerous sources since ÿ
the initial purification and characterisation of PDC from Escherichia coli (Koike et al.,
1960, 1963; Reed and Willms, 1965; Linn etaL, 1972; Danson etciL, 1979; Henderson 
and Perham, 1980; Stanley and Perham, 1980; Kresze and Ronft, 1981; Jaenicke and 
Perham, 1982). In eukaryotes, the complexes are present in the mitochondria and have 
high Mr values (2.5 x 10^ to 9.0 x 10^) (Linn et al, 1972). They can be seen as particles 1
■ î
of 30 to 40 nm in the electron microscope and are significantly larger than ribosomes i
'I(Oliver and Reed, 1982).
I
1.1.2 Reaction sequence of the 2-oxoacid dehydrogenase complexes
The 2-oxoacid dehydrogenase complexes catalyse the decarboxylation and 
dehydrogenation of 2-oxoacids in a sequential and co-ordinated multistep process 
involving the activities of multiple copies of three separate enzymes to generate CO 2 
and the corresponding acyl CoA and NADH (Reed, 1974; Yeaman, 1989). The overall
,1reaction catalysed by the 2-oxoacid dehydrogenases can be summarised as follows:
_____________________________
RCO-COOH + CoASH + NAD+^ ■^RCOSCoA + CO2 + NADH + H+
These complexes were first postulated to be one of the classic examples of a "swinging 
arm" mechanism (Reed, 1974; Hammes, 1981), whereby rotation of the substrate is 
permitted between the three active sites in the constituent enzymes whose participation 
is required in the overall catalysis. More recently it has been found that the swinging 
arm alone is not sufficient to allow adequate rotation of the substrate, and that the whole 
lipoyl domain has a highly flexible conformation. Figure 1.2 schematically represents 
the reaction mechanism of the 2-oxoacid dehydrogenase complexes where each 
component has a specific role in the catalytic process. The substrate-specific El enzyme 
(2-oxoacid dehydrogenase), which requires thiamine pyrophosphate (ThDP) as an 
essential cofactor, catalyses the decarboxylation of the appropriate 2-oxoacid with the 
formation of a ThDP intermediate and a molecule of CO2- El is also responsible for the 
reductive acylation of the lipoic acid moiety which is covalently attached to 
dihydrolipoamide acyltransferase (E2) as is discussed later. E2 transfers the acyl group 
to the CoA acceptor leaving the dithiolane ring of the lipoic acid in the reduced state. E2 
also forms the structural core of the complexes and is arranged in octahedral (24 
subunits) or icosahedral (60 subunits) symmetry depending on the specific complex, and 
in the case of PDC on the source of the complex (see section 1.2.2). Dihydrolipoamide 
dehydrogenase (E3) then reoxidises the lipoamide group, transferring the reducing 
equivalents onto NAD+ via its tightly bound FAD cofactor (Brown and Perham, 1976).
:..0
:
I
"if«.:|i
■■a
a'- '-a. ' a - '.: : -a.r '
Pymvate
PDCLeucineIsoleucineBCDC
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ValineMethionineTlueonine
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Figure 1.1 An outline of the tricarboxylic acid cycle illustrating the pivotal 
positions of the 2-oxoacid dehydrogenase complexes in central metabolism
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Figure 1.2 Schematic representation of the reaction mechanism of the 2-oxoacid 
dehydrogenase complexes highlighting the specific reactions catalysed by the 
component enzymes
I
I
I
•i
I
i
■ ■
1.2 COMPONENT ENZYMES OF 2-OXOACID DEHYDROGENASE 
MULTIENZYME COMPLEXES
1.2.1 2-oxoacid dehydrogenase (El)
The 2-oxoacid dehydrogenase (El) component catalyses the only irreversible 
reaction in the miiltistep activity of the 2-oxoacid dehydrogenases. This is the first 
reaction in the complex: the thiamin diphosphate-dependent oxidative decarboxylation 
of the 2-oxoacid is followed by the reduction of the lipoyl group covalently bound to a 
specific lysine residue of the E2 lipoyl domain. To enable this reaction to proceed, El 
non-covalently binds thiamin diphosphate (ThDP), a cofactor widely employed by 
enzymes catalysing reactions involving the rupture of the carbon-carbon bonds adjacent 
to a 2 - 0 X 0  (keto) group. The decarboxylation step is the rate-limiting step in the overall 
reaction catalysed by the complexes (Danson etal., 1978; Akiyama and Hammes, 1980; 
Cate etal., 1980). The reaction is thought to proceed via a covalent adduct of ThDP with 
the formation of a ThDP-bound intermediate and one molecule of CO2 (Reed, 1974).
There are two different forms of the El component. The first is a homodimer 
(a2) with a subunit Mr of approx. 100 000 and is found in octahedral OGDC and PDC. 
The second is a heterotetramer (a2P2) with subunit Mr values of approximately 41 000 
and 36 000 respectively and is found in the octahedral BCDC and icosahedral PDC. In 
the heterotetrameric form, the El a  subunit appears to comprise two large domains with 
Mr values of 31 000 and 10 000 (Koike et al., 1992). The genes encoding the El a  and 
Elp chains of PDC and BCDC and the unsplit E l chain of OGDC may share a common 
ancestor (Matuda etal., 1991). However, sequences available for E l of PDC and OGDC 
show little homology even when extracted from the same source (Daiiison et al., 1984), 
As an example, the El chains from E. coli PDC and OGDC show a pronounced lack of 
sequence similarity (Guest etal,, 1989). A 30-amino acid residue motif has, however,
‘■'.'S-';
1.2.2 Dihydrolipoamide acyltransferase (E2)
domain, as well as the "swinging arm", is intrinsic to the coupling process (Miles etal., 
1988; Machado etal., 1993). The role of the lipoyl domains is that of guiding the
been identified in all known ThDP-dependent enzymes, irrespective of their lack of 
sequence homology, which is predicted to be involved in ThDP binding (Hawkins et al.,
1989). 2
The dihydrolipoamide acyltransferase (E2) component of the complexes is the 
key to their structure and function. It has three major roles. Firstly, it forms a structural 
core to which the El and E3 components bind. Secondly, it is an acyltransferase,
:catalysing the formation of the acyl-CoA product. Thirdly, it provides the attachment
I4
site for the lipoic acid cofactor which interacts with the different active sites in the 
complexes. All E2 enzymes possess highly segmented structures containing several 
functional domains (Bleile etal., 1979; Perham 1991). A schematic representation of the
domain structure of E2 from various sources is shown in Figure 1.3. The C-terminus of I?'2
the E2 polypeptide forms a compact inner domain which contains the E2 binding sites 
allowing the E2 polypeptides to interact with each other to form the core of the complex.
This domain also contains the catalytic activity of E2 (Packman etal., 1988). Adjacent 
to this domain, there is a distinct region of polypeptide consisting of approximately 50 
amino acids which is responsible for the binding of E3 to the central core. At the N- 2
terminus of the E2 polypeptide are the lipoate domains. The lipoyl moieties are attached 
via an amide linkage to the 8-amino group of a lysine residue within a lipoate domain.
This linkage provides a flexible arm about 14 Â in length permitting the lipoyl moiety to
rotate amongst the active sites of E l, E2 and E3 in what is called a "swinging arm"
i2active site coupling mechanism (Koike et al., 1963). The flexibility of the whole
cofactor lipoamide through the various active centres. In order to promote reductive
:
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acylation of the dithiolane ring by the El component, the lipoyl group must be attached 
to a specific lipoyl domain. This indicates that the decarboxylase subunit binds and 
recognises the domain itself and not only the lipoyl group (Packman et al., 1988).
The complexes vary in the number of lipoyl domains which are present in the E2 
polypeptide. E2 from PDC of E. coli is remarkable in that it contains three highly- 
conserved lipoyl domains (Stephens e ta l, 1983). Surprisingly, deletion of two of the 
three lipoate domains by site-specific mutagenesis still allows assembly of a functional 
complex with full catalytic activity (Guest etal., 1985). The catalytic activity can be 
abolished when all three domains are deleted or rendered unlipoylatable by lipoyl- 
Lys-»Gln substitutions (Allen eta l, 1989). Complexes containing mixtures of wild-type 
and mutant lipoyl domains possess high levels of activity, although some impairment 
has been reported when the only wild-type domain is the one closest to the peripheral 
subunit binding domain (Allen eta l, 1989). Presumably this is a reflection of the 
reduced conformational flexibility of this construct. A reduction in complex activity is 
also observed by increasing the number of lipoyl domains to between four and nine per 
E2 chain. Under-lipoylation of the domains participating in catalysis and steric 
hindrance from unlipoylated domains are thought to be involved in the partial activity 
loss (Machado eta l, 1992). As the additional domains are not required for the catalytic 
functioning of the complex, the interesting question remains as to the purpose of this 
duplication. However, while deletion of two of the three E. coli lipoyl domains still 
allows a complex with full catalytic activity to assemble, there is evidence that when 
these bacteria are cultured with wild-type E. coli, the wild-type has a greater growth rate 
(Guest et al, 1985). This is thought to be due to the increased flexibility of the outer f ;
lipoyl domain allowing the surrounding El components to be serviced more effectively. ;|
The domains are joined together by conformationally flexible linker regions, rich in 
alanine, proline and acidic residues, which facilitate active site coupling. The importance fIof these linker regions to a high catalytic efficiency is inferred from the impairment that #
accompanies the deletion or shortening of these sequences, and by the enhancement 
which occurs on incorporating a polyproline linker (Miles etal.y 1988; Turner etaL, 
1993).
It has been found that the domain sequences are sufficiently well-conserved in 
evolution for analogous segments to be clearly identified in E2 components of all of the 
2-oxoacid dehydrogenase complexes studied so far. As well as the variations in the 
number of lipoate domains per E2 chain, however, differences are also apparent in the 
lengths and compositions of the interdomain linker sequences (Guest etaL, 1989; 
Perham and Packman, 1989). A search for amino acid sequences similar to the C- 
terminal domain of the E2 subunit of E. coli PDC has found nine sequences with 
extensive similarity, eight of which are E2 subunits from a variety of species (Russell 
and Guest, 1991). The other was for a mitochondrial ribosomal protein, MRP3, from 
Neurospora crassa, now also thought to be an E2 component. Russell and Guest (1991) 
have compared 13 E2 sequences, including those from human, bovine, rat, yeast and E. 
coli sources. This study has revealed that 34% of the aligned residues are identical or 
show a high degree of conservation and has also helped identify residues which are 
potentially important for structure, catalytic activity and substrate-specificity of the 
acyltransferases.
The E2 components of the complexes are arranged with point group symmetry. 
OGDC and BCDC have 24 copies of E2 arranged with octahedral (cubic) symmetry as 
does PDC from Gram-negative bacteria. In contrast, PDC from mammals, birds, yeast 
and Gram-positive bacteria have 60 copies of B2 arranged in icosahedral symmetry 
(Perham etaL, 1987). The structure and molecular architecture of the 2-oxoacid 
dehydrogenase multienzyme complexes is discussed in more detail in a later section.
Dihydrolipoamide + NAD+ ^ ^Lipoamide + NADH + H+
During the reaction, electrons are transferred from lipoamide first via the 
disulphide/di thiol and then via its cofactor FAD to NAD+ as the final electron acceptor
Î
I
1,2.3 Dihydrolipoamide dehydrogenase (E3)
Dihydrolipoamide dehydrogenase (E3) is responsible for the NAD+ dependent 
re-oxidation of the dihydrolipoamide groups present on the E2 components, thus 
allowing the acyltransferase component to re-enter the catalytic cycle (Yeaman, 1989),
itE3 also functions as an integral component of the glycine decarboxylase complex 
(GDC) which, like the 2-oxoacid dehydrogenase complexes, is located in the 
mitochondrion in eukaryotic cells. E3 has also been discovered in the absence of the 
aforementioned complexes. In the bloodstream form of Trypanosoma brucei there is a
single mitochondrion and an absence of the multienzyme complexes mentioned above. If
E3 has been found located outside the mitochondrion, associated with the plasma II
Imembrane (Danson et aL, 1987; Jackman et al., 1990). Serrano (1992) has reported the 
presence of E3 activity in two cyanobacteria, the unicellular Synechoccus PCC 6301 and 
the filamentous Anabaena cylindrica. The 2-oxo acid dehydrogenase complexes are 
believed to be absent in filamentous cyanobacteria (Smith, 1973; Bothe and 
Nolteernsting, 1975). Since a low GDC activity was detected in cell free extracts of 
Anabaena cylindrica ,the function of cyanobacterial E3 remains unclear. It has been
■Isuggested that E3 may be involved in a glycine cleavage system (Serrano, 1992). The I
overall reaction catalysed by E3 is:
■1.
(Ghisla and Massey, 1989). All E3 enzymes isolated to date have been found to be ÿ
homodimers with a subunit Mr of approximately 50 000. Each subunit contains a |
1 0  i, V.7?
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molecule of non-covalently bound FAD. Four distinct domains can be identified within 
each monomer. From the N-terminus these are; an FAD binding domain, an NAD 
binding domain, a central domain and an interface domain. The structural similarities 
between the FAD and NAD binding domains suggest that they may have evolved from a 
common ancestor.
E3 has been isolated from a wide variety of sources and is generally believed to 
be the identical gene product in all three members of the 2-oxoacid dehydrogenase
■3complexes as well as in GDC (for a review, see Carothers et ai, 1989). However, there k
Iis some conflicting evidence suggesting the existence of isoforms of E3. In rat liver 
mitochondria two immunologically distinct forms of E3 have been identified. It has been 
suggested that from this source the E3 associated with GDC is different from that 
associated with the 2-oxoacid dehydrogenase complexes (Carothers et al., 1987).
-I:'The sequencing of E3 enzymes from a wide variety of sources has provided 
much information allowing comparisons to be made between species. It has been shown 
that E3 is a highly conserved enzyme across species. For example, the sequence of 
human liver E3 exhibits 96% homology with that of E3 from porcine heart (Otulakowski 
and Robinson, 1987) and 44% identity with E. coliE5 (Pons etaL, 1988). Three 
dimensional structures have also been determined for E3 components from several 
sources including yeast (Takenaka etaL, 1988), Pseudomonasputida (Mattevi etaL,
1992a) and Pseudomonas fluorescens (Mattevi et al., 1992b). It has also been reported 
that E3 exhibits both structural and functional similarities with several members of the 
pyridine nucleotide disulphide oxidoreductases, in particular with glutathione reductase i|
(GR) (Takanaka et al., 1988). GR is responsible for catalysing the NADPH dependent 
reduction of glutathione disulphide. Therefore E3 and GR act in opposite directions by 
passing reducing equivalents to NAD+ or from NADPH respectively. Both enzymes 
contain a redox-active disulphide bridge that undergoes oxidation-reduction during I
catalysis causing them to cycle between oxidised and 2 electron reduced forms
•'7 7 - • - ■ • .  •_   . . _ . . . . .     .. .
(Williams et ai, 1989). As well as GR and E3, other members of the family of 
.homodimeric FAD-dependent disnlphide oxidoreductases include mercuric reductase, 
thioredoxin reductase and trypanothione reductase. E3 is the only member of this family 
that belongs to a multienzyme complex, although an increasing number of non-complex 
bound functions of E3 are being reported, (Williams, 1992 and references therein) as 
discussed earlier in this section.
Each subunit of E3 binds non-covalently a molecule of flavin adenine 
dinucleotide (FAD). Attachment of this cofactor is thought to occur during the folding of 
mature polypeptides within the mitochondrion and it has previously been suggested that 
this may represent a key step in the folding of E3 and the subsequent assembly of the 
mature complex (Yeaman, 1986). The involvement of FAD in the folding of E3 is 
investigated further in Chapter 5.
1,2.4 Component X
In addition to its three constituent enzymes, mammalian PDC has been found to 
contain a tightly-associated 50 0(X)-Mr polypeptide termed component X (De Marcucci 
and Lindsay, 1985). It was initially suggested that component X was a proteolytic
fragment of E2, but this suggestion was ruled out using refined immunological 
techniques employing subunit-specific antisera and the finding that anti-X serum elicits 
no cross-reaction with the other components including the intrinsic kinase of PDC (De 
Marcucci and Lindsay, 1985). Component X has been found to contain an additional 
lipoate domain and it was first thought that there were about 6 copies of the protein per 
complex (Jilka etaL, 1986; Hodgson etaL, 1986). More recent evidence suggests that 
there are 12 copies of X in bovine PDC, although it is not yet known if they are bound to 
the complex individually or as 6 dimers (Sanderson et aL, 1996). A similar protein has 
been found in PDC from yeast (Behai et aL, 1989). There is no evidence to date for the
12
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existence of a component X in PDC from prokaryotes, nor in OGDC or BCDC, but this 
possibility cannot be ruled out at present.
The role of component X in PDC remains unclear. Limited proteolysis of 
component X in mammalian PDC leads to a lower affinity of E3 for the core assembly, 
so one possibility is that it is involved with the binding of the E3 component and 
facilitating its participation in electron transfer (Gopalakrishnan et aL, 1989; Neagle et 
aL, 1991; Lawson et aL, 1991). Mutagenesis of the yeast gene for component X has 
indicated that it is not required for the formation of the E2 core, that it is essential for E3 
binding and that the lipoyl domain can be deleted without effect (Lawson etaL, 1991). 
Its lipoyl domain, though capable of becoming reductively acetylated (Jilka et aL, 1986;
Hodgson etaL, 1986), apparently serves no catalytic function. I I:
1.3 COMPLEX CONTROL
PDC is well designed for fine regulation of its activity. Phosphorylation of the I
El subunit causes inactivation of the complex by a dramatic reduction of the Vmax- IInterconversion of the active and inactive forms of El is a dynamic process that leads
rapidly to the establishment of steady states, in which the fraction of phosphorylated f
enzyme can be varied over a wide range, BCDC is controlled in a similar fashion, 
although the kinases and phosphatases are specific for each complex. The kinases are 
tightly bound to, and copurify with, their respective complexes, whereas the 1; j
phosphatases are loosely associated and are purified as distinct, soluble enzymes. The 
pyruvate dehydrogenase kinase has been purified to apparent homogeneity from extracts 
of bovine kidney mitochondria and its structure elucidated (Stepp et aL, 1983). It is a 
hetero-dimer consisting of subunits termed a  and jJ, which have molecular masses of 48 
000 and 45 000 respectively. Limited proteolytic studies first indicated that the a- 
subunit contained the kinase active site and that the (3-subunit may serve a regulatory
■I
I
I#role (Stepp etaL, 1983). Using purification, N-terminal sequencing and cDNA cloning 
and sequencing, rat heart has been shown to contain two PDC kinases, termed p45 and
14
Ip48. Northern blotting has shown that mRNA for p45 is abundant in most rat tissues 
studied whereas p48 is abundant only in heart (Popov etal., 1993; Popov etaL, 1994).
Limited immunological data suggest that the bovine kidney kinase ot-subunit may 
correspond to rat heart p45 (Priestman et aL, 1994). Kinase activity appears to be 
specific for pyruvate dehydrogenase as little activity is exhibited toward a number of 
other substrates including BCDC, rabbit skeletal muscle phosphorylase b, glycogen 
synthase a, histones or casein (Reed et aL, 1985). The kinase has been found to 
phosphorylate three serine residues on the a-subunit of El (Yeaman, etal., 1978;
Sugden et aL, 1979). Phosphorylation occurs markedly faster at site 1 than at the other y
two sites, and phosphorylation at site 1 correlates closely with inactivation of El. The 
activity of the kinase is stimulated by acetyl-CoA and NADH, products of the complex, 
and this stimulation is antagonised by the substrates CoA and NAD+. Inhibition is also 
caused by pyruvate and by ThDP, which presumably binds directly to the active site of 
the El substrate and thereby alters the conformation about phosphorylation site 1 so that
Î
"3the serine hydroxyl group is less accessible to the kinase (Reed and Yeaman, 1987). :IPyruvate dehydrogenase phosphatase has been isolated from bovine heart and 
kidney mitochondria (Teague et at., 1982; Pratt et at., 1982). It has been found to have a 
molecular mass of approximately 150 000 and consists of two subunit types, the 
catalytic activity residing in a subunit of 50 (XX) and the larger subunit containing a 
molecule of FAD (Teague et at., 1982). The phosphatase is highly specific for PDC,
with minimal activity against phosphorylated BCDC (Damuni et aL, 1984). Also, it has I ;7
been found that the phosphatase has an absolute requirement for Mg^+ and is stimulated 
by micromolar concentrations of Ca^+ which act by promoting binding of the 
phosphatase to the E2 core of the complex, NADH inhibits phosphatase activity, and 
this inhibition is reversed by NAD+ (Pettit et at., 1975). The amino acid sequences of
'
1.3.1 Acute control of the complexes
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pyruvate dehydrogenase phosphatases from several sources have recently been deduced.
Sequence alignment of sequences from rat (Tamura etal., 1989), rabbit and human
(Mann eta l, 1992), Saccharomyces cerevisiae (Maeda et aL, 1993) and the protozoan
parasite Leishmania chagasi (Burns etal., 1983) has revealed five distinct regions of
. .significant sequence identity. Site-directed mutagenesis is being carried out with the
pyruvate dehydrogenase phosphatase catalytic subunit to ascertain whether the highly 
conserved residues are involved in Mg^+ binding, substrate binding and/or catalysis 
(Reed etal., 1996).
As the 2-oxoacid dehydrogenase complexes occupy key positions in :p
intermediary metabolism it is essential that their activities be precisely regulated. All 
members of the family are subject to product inhibition which is reversed competitively 
by the substrates. The activities of both OGDC and PDC are also subject to control by 
changes in the intramitochondrial concentrations of free Ca^+ (Denton and McCormack, 
1985). The effect of Ca^+ ions on OGDC is via direct binding to the complex, causing 
allosteric activation by reducing the Km for the substrate, 2-oxoglutarate (Lawlis and 
Roche, 1981). This effect is antagonised by ATP which increased the Km for 2- 
oxoglutarate. This mechanism is thought to underlie the activation of OGDC by Ca^+- 
mobitising hormones such as vasopressin and the a-adrenergic action in liver (Denton 
and McCormack, 1985). PDC can also be activated by such hormones, however, this 
activation is not via direct allosteric activation but via stimulation of PDC phosphatase 
as discussed in the previous section.
1.4.1 Mitochondrial targeting and assembly
PDC, OGDC and BCDC in eukaryotes are located in the mitochondrion, 
probably in loose association with the inner face of the inner membrane. The individual
16
1.4 STRUCTURE OF THE 2-OXOAClD DEHYDROGENASE MUETIENZYME 
COMPLEXES
.The structure of these complexes is such that a number of E2 polypeptides form 
a core around which are arranged multiple copies of El and E3 components which bind .'Inon-covalently (Reed, 1974). As mentioned in section 1.2.2, the arrangement of the E2 
core is complex and species-specific as there are two distinct core structures, the cube 
and the pentagonal dodecahedron. OGDC and BCDC have 24 subunits of E2 arranged 
with octahedral symmetry as does PDC from Gram negative bacteria such as E. coli as 
illustrated in Figure 1.4 (Oliver and Reed, 1982). The second E2 core arrangement is
i
I
composed of 60 subunits arranged with icosahedral symmetry and is found in PDC from
Gram positive sources, yeast such as S. cerevisiae, and also from mammalian, avian and
.fungal sources (Perham, 1991). In E2 cores with octahedral symmetry, twelve El dimers 
bind along the twelve edges of the core and six E3 dimers bind along the six faces. In 
E2 cores with icosahedral symmetry, 20-30 El tetramers bind to the thirty edges and 
again six E3 dimers bind to six of the twelve faces of the pentagonal dodecahedron 
(Reed et aL, 1975; Barrera etal., 1972). The number of E3 dimers bound to each 
complex, however, has recently been reexamined due to the evidence that component X 
facilitates the binding of E3 dimers to the complex in PDC (Lawson et aL, 1991 ; De 
Marcucci etal., 1995). As evidence suggests that there are 12 copies of component X in 
bovine PDC, up to 12 E3 dimers could be bound to the core complex (Sanderson et aL, 
1996).
Figure 1.4 Model of the pyruvate dehydrogenase complex from E. coli
The transacetylase core (E2) is shown hatched, the pyruvate dehydrogenase 
component (El) is shown in black and the dihydrolipoyl dehydrogenase component (E3) 
is shown in white. This figure is reproduced from Stryer (3rd edition, p381).
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polypeptides of the complexes are nuclear coded, since all the translation products of the 
mitochondrial genome have been identified as components of the major respiratory 
chain complexes of the inner membrane involved in oxidative phosphorylation (Chomyn 
et al., 1985). The translocation and assembly of such large complexes is necessarily a 
multistage process involving a sequence of molecular events, the details of which are 
gradually being elucidated.
As with the majority of mitochondrial precursors, the initial cytosolic translation 
products of the components would each be expected to contain amino-terminal 
extensions which are proteolytically cleaved during or shortly after entry into the 
organelle. This has been found to be the case for each of the complexes, PDC (Hunter 
and Lindsay, 1986), OGDC (De Marcucci eta l, 1988) and BCDC (Clarkson and 
Lindsay, 1991). The E2 components of the complexes, however, have been found to 
possess extended presequences, approx. 55-75 amino acids in length (Lindsay, 1989). 
There is some evidence that elongated signal sequences contain additional information 
to that which is present in shorter (25-35 amino acid) amino-terminal sequences, perhaps 
to specify more precisely the delivery destination i.e. the inner membrane, outer 
membrane or intermembrane space (Hurt etal., 1985). Chaperone proteins may well be 
involved in maintaining the individual polypeptides in a loosely-folded state which is 
required to facilitate their movement across organelle membranes and may also be 
involved in their folding once inside the mitochondrion, which is discussed further in 
Chapter 5. In vitro evidence that bovine PDC can regain full catalytic activity when its 
purified native components are mixed in the absence of chaperone proteins, suggests that 
their assistance is not required in the assembly of the folded components within the 
mitochondrion. As the E2 and X subunits form the core to which the other components 
of the complex bind, the construction of the correct core conformation probably holds 
the key to the assembly of the complexes. Three general schemes of assembly of the 
central core can be envisioned. Firstly a sequential mechanism, in which individual
I
1.5 PHYSIOLOGICAL DISORDERS
Imonomelic subunits are combined to generate progressively larger E2-X multimers, 
with one subunit being added at each step. Secondly a random mechanism, in which 
different oligomeric structures, composed of varying numbers of individual E2 subunits,
A;combine spontaneously to form the final structure. Thirdly an ordered mechanism in
which a single defined oligomeric E2 intermediate assembles into progressively larger
I;:
I-
E2-X structures, Behai et a.L (1994) have found evidence supporting the third suggested
Imechanism using sedimentation velocity analysis on reassembling E2-X complexes. The 
detection of a stable 8 S oligomeric structure strongly suggests that there is a key 
assembly intermediate between the monomeric 1.5-3 S species and the mature 32 S E2- 
X subcomplex in bovine PDC. This assembly intermediate is widely believed to be a 
trimer (Behai eta l, 1994; Wynn eta l, 1994). Component X is not thought to be 
influential in the E2 assembly process. Lawson etal. (1991) demonstrated that 
component X is not required for E2 assembly in yeast PDC, Bovine PDC E2 has also 
shown reversible dissociation in the absence of component X (De Marcucci et al, 1995),
3 I
The importance of the 2-oxoacid dehydrogenase complexes and their control is 
demonstrated by the occurrence and severity of a number of related disorders.
Primary biliary cirrhosis (PBC) is a chronic liver disease characterised by 
progressive inflammatory destruction of intrahepatic bile ducts which leads to fibrosis, 
liver cell damage and ultimately liver failure (Kaplan, 1987; Sherlock and Dooley,
1993). PBC-specific auto-antibodies can be detected by indirect immunofluorescence 
(Walker eta l, 1965). A serological marker for the diagnosis of this autoimmune process 
is the presence of antimitochondrial autoantibodies directed against a family of antigens 
termed M2. Several constituents of the M2 antigens are components of PDC, OGDC and 
BCDC. The major autoantigen is believed to be the PDC E2 component (Palmer etal.. I
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1993) and the lipoic acid moiety is thought to play an important role in antibody 
recognition (Fussey e ta l, 1990).
Various forms of metabolic acidosis can be traced to regulatory abnormalities of 
the 2-oxoacid dehydrogenase complexes, such as Maple Syrup Urine Disease (MSUD). 
This autosomal recessive inborn error of metabolism results in an accumulation of 
branched-chain amino acids in the urine of sufferers and was first characterised by its 
high prevalence in the Mennonite populations of Pennsylvania (DiGeorge, 1982).
Several phenotypes have been described, ranging from the classical form, characterised 
by severe mental and physical impairment and early death (Menkes eta l, 1954; Dancis 
eta l, 1959), to a number of milder conditions with later onset (Dancis etal, 1967; 
Schulman eta l, 1970; Scriver etal., 1971). Molecular analysis of BCDC in cell lines 
derived from patients with MSUD has revealed that the mutations causing this disease 
are heterogeneous and include missense, deletion, insertion and splicing abnormalities of 
any subunit of BCDC (reviewed by Indo and Matsuda, 1996).
Blass et al. (1971) documented a second inborn error of metabolism involving 
deficiencies of PDC causing abroad spectrum of conditions characterised by low 
complex activity (below 30% of normal). These deficiencies are associated with primary 
lactic acidosis and neurological disabilities of varying severity including Leigh’s disease, 
an autosomal recessive condition affecting normal brain function (Johnston et al, 1984). 
Until relatively recently, little was known of the genetic mutations associated with these 
conditions. Since complex activity depends on the correct translation of El, E2 and E3 
(and in PDC El a, E ip and X) as well as the regulatory enzymes, mutations in many 
gene loci are possible. Using assays of individual component activities, immunological 
screening with component-specific antisera and assessment at the mRNA level 
employing cDNA clones encoding individual components, several types of specific
20
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El a  gene on chromosome X in haploid spermatozoa is resolved by testis-specific
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Igenetic mutations have been identified. The most common form of PDC deficiency is 
due to mutations located in the El a  gene of chromosome X (Robinson et al., 1989). 
Initial information suggested that males were more severely affected by such mutations, 
the frequency and range of severity being greater in females. However, due to the 
unpredictable patterns of inactivation of the 2 X-linked El a  alleles in females, there is a 
variable degree of penetrance, especially within the brain (Brown et al., 1989). While 
mutations found in males appear to be associated with predicted preservation of minimal 
El a  function, heterozygous females can survive with certain mutations that would not 
be predicted to have any residual function. In such females, cells in which the normal 
allele is expressed should function normally, while neighbouring cells expressing the
abnormal allele would not be expected to survive (Dahl, 1995). It is still unclear which
'stage of development may be the most vulnerable to the deficiency caused by these
.mutations. During normal male reproduction, the problem of lack of expression of the
expression of the E la  gene on chromosome 4 (lannello etal., 1993). It is possible that
ova containing a defective El a  allele which is not able to produce any PDC activity may
not survive in the ovary, accounting for the apparently frequent disappearance of these
.alleles (Kerr et al., 1996). The notable rarity of E3-linked deficiencies reflects the 
severity of the associated condition. Impairment of E3 function causes a reduction in all 
three 2-oxoacid dehydrogenase complex activities resulting in the accumulation of 
lactic, 2 -0 X 0 - and branched-chain amino acids and their derivatives in the plasma and 
urine of sufferers (Liu etal., 1993).
It has been suggested that deficiencies in OGDC activity are linked to 
Alzheimer’s disease. Lowered interconversion between 2-oxoglutarate and glutamate, 
caused by impaired 2-oxoglutarate oxidation, is believed to result in the accumulation of 
glutamate, a potent neurotoxin when energy metabolism is suppressed (Beal, 1992).
Sheu et al. (1994) have studied cultured skin fibroblasts from familial Alzheimer
22
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patients. Their studies have revealed defective OGDC activity and abnormalities of the 
E2 component. Other mitochondrial proteins including PDC were found to have normal 
activity levels. Mutations in the gene encoding E2 may cause the defect in OGDC 
activity. I
3
1.6 THE PROTEIN FOLDING PROBLEM I;
The first half of the genetic pathway whereby information from DNA is 
transferred into a three-dimensional functional protein has been well characterised. Until 
relatively recently, however, little research has been undertaken to elucidate the steps 
undergone by the nascent polypeptide during and after emerging from the ribosome to iS
reach its final native structure. Pioneering work by Christian Anfinsen beginning in the 
1960s on bovine pancreatic ribonuclease led to the acceptance of the thermodynamic 
hypothesis which states that the amino acid sequence of a given protein determines its 
tertiary structure (Anfinsen, 1973). The extrapolation from early experimental results of 
this type was that a protein in vivo could fold and assemble spontaneously in a process 
intrinsic to its primary structure, independent of other factors. Levinthal (1968) has 
estimated that it would take in the order of 10^^ years for a polypeptide of 100 amino f
.aLvacid residues to reach a particular conformation by random processes and although the '
I:figure is probably a little lower when taking steric hindrance into account, it is obvious 
that an ordered folding pathway of some description is in operation. The way in which 
amino acid sequence dictates tertiary structure, however, is not a simple code like the 
mRNA triplet code. It can be shown that amino acid substitutions are allowed at many 
residue positions without drastic changes in the folding pattern. Furthermore strikingly
similar structures have been determined for evolutionary distant proteins with only a few
amino acids in common. Determining the folding pathway may be the principal means 
of understanding the complexity of the folding process itself.
A general folding pathway for monomeric proteins may be described in simple 
terms by the equation
fast slow
where U, I and N represent the unfolded, intermediate and native states, respectively. 
The initial fast steps in protein folding involve the rapid formation of secondary 
structure, which occurs on the millisecond time scale, and the formation of an 
intermediate structure represented by I in the above equation (Ptitsyn et a l, 1990; 
Christensen and Pain, 1991). This intermediate state, termed a molten globule or 
compact folding intermediate, differs from the native by the absence of close packing 
throughout the molecule and by a substantial increase of fluctuations in side chains as 
well as of larger segments of the molecule. The molten globule form exists in rapid 
equilibrium with the unfolded state. The rate determining step in protein folding is the 
transition from I to the native state, a process which involves changes in tertiary 
structure. Not all proteins have been found to fit with this framework model. For 
example the folding of barstar, the inhibitor of barnase in the bacterium Bacillus 
amyloliquefaciens, can be explained better by the hydrophobic collapse model (Agashe 
e ta l, 1995). This model gives overriding precedence to a non-specific collapse of the 
polypeptide chain which facilitates subsequent formation of specific secondary and 
tertiary structures.
The folding process is not always completely successful as incorrect intra- or 
inter-polypeptide interactions can take place. This can lead to the formation of inactive 
aggregates and has been observed in vitro where the yield of refolded protein varies 
greatly depending on the chosen conditions and in vivo in the case of formation of
23
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1.6.1 Comparing in vitro and in vivo protein folding
■A
inclusion bodies during protein overexpression (LaVallie etal., 1992) or during heat
shock and other stress conditions within the cell (Parsell etal., 1993). Aggregation of
this type is thought to be caused by the exposure of hydrophobic residues on the molten
.globule. A growing list of human diseases are being found also to involve altered protein 
folding. Cystic fibrosis, for example, has been found to be caused by mutations of the 
gene encoding an ATP-dependent Cl" channel called the cystic fibrosis transmembrane 
conductance regulator (CFTR). In 70% of cases the mutation is a deletion of residue 
508, located in the amino-terminal nucleotide-binding domain of this five domain 
protein. As a consequence. Cl" conductance is decreased in diseased epithelial cells. 
Thermodynamic studies in vitro have shown that this mutation does not have a large 
effect upon the stability of the native state, which is functional under physiological 
conditions, but dramatically destabilises a 67 amino acid peptide model of a folding 
intermediate (Thomas etal., 1992). These findings strongly suggest that the defect is in 
the folding pathway itself (Thomas etal., 1995).
■:r
The traditional approach to studying the folding process, with a view to 
understanding the pathway involved, is to investigate the purified protein in an in vitro 
system. Chaotropic agents are used to denature the protein and these agents are then 
removed to initiate refolding. Commonly used chaotropes include urea and guanidinium 
chloride (GdnHCl) which unfold the protein by interfering with hydrophobic 
interactions. In many studies, these agents have helped provide information on the 
structure of intermediates on the refolding pathway using techniques such as circular 
dichroism and fluorescence spectroscopy, ^H-exchange NMR, gel exclusion 
chromatography, urea gradient gel electrophoresis and analytical ultracentrifugation (e.g. 
Holladay etal., 1974; Christensen and Pain, 1991; Zhi etal., 1992; Behai etal., 1994).
24
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Protein folding in vivo, however, happens cotranslationally, that is, elements of 
secondary structure, or even whole domains, can fold before the synthesis of the 
polypeptide is complete. Indeed, it has been found in many cases that protein refolding ' A3
occurs more quickly than its synthesis in the cell. Failure of a protein to refold may be
caused in some cases by the sequential nature of the process. For example, when the
synthesis of a polypeptide consisting of 100 amino acids is complete, around 40 residues
remain within the ribosome. Unfolding the native state of such a protein cannot therefore
recreate the conditions experienced by the nascent chain, and may effect the folding
process. Following co- and post-translational events within the cell is a relatively recent
field and poses many practical problems, despite which some interesting progress is
being made. Allen etal. (1995) have investigated the co-translational A-linked
glycosylation of tissue-type plasminogen activator (t-PA) in cell culture. This study uses
a pulse-chase approach in conjunction with immunoprécipitation and reducing and non-
reducing SDS-PAGE to demonstrate that folding and disulphide bond formation in t-PA
determines its extent of core A -^linked glycosylation.
In vitro, aggregation can be suppressed by varying the conditions of the refolding
environment. The temperature, pH and protein concentration of an optimum refolding 
.reaction can be far removed from the situation encountered by the same protein in the
7 '
cell. Indeed in the highly viscous intracellular environment where protein concentration
can be 200 mg/ml it is unclear whether spontaneous folding is possible at all.
.........................................Refolding in vitro varies in time from seconds to hours and is often dependent on
the chosen experimental conditions. Indeed some proteins, particularly multi-subunit
ones such as glutamate dehydrogenase, have eluded all attempts to refold after unfolding
of the polypeptide chains to date. There are many factors which govern the differences
observed in the efficiencies of nascent folding and refolding respectively. As the length
of a polypeptide chain increases, there is a tendency to form domains within the chain
which can unfold and refold independently. The rate limiting step in the formation of
1
1.7 CATALYSIS OF PROTEIN FOLDING
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active protein is often the correct ’pairing’ of these domains. During the biosynthesis of 
proteins, it is likely that co-translational folding may help to prevent incorrect pairing by 
allowing domains to fold sequentially (Jaenicke, 1981 ; Tsou, 1988). Also, pauses in 
translation due to rare codons may give time for structural correction and adjustment 
during biosynthesis (Purvis etal,, 1987). Part of the discrepancy between in vivo and in 
vitro (re)folding can be accounted for by the fact that the cell contains additional 'tools' 
for efficient folding, such as protein disulphide isomerase, peptidyl prolyl cis-trans 
isomerase and chaperone proteins, which are discussed in more detail in the following 
sections.
Despite the discrepancies between the time-scale of (re)folding, the product of
the in vitro or in vivo pathway is a protein with identical conformation, biological |
'3activity and relative molecular mass for a given substrate (Jaenicke, 1987). This would 
suggest that the in vitro method of studying protein folding is indeed a valid way of 
providing valuable information about the folding process. There are benefits and 
drawbacks of studying both the in vivo and in vitro systems, but it is clear that the whole 
picture will only be obtained by combining results from both types of experiments.
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The rate-determining steps of protein folding in vitro, and thus presumably in I -
vivo, involving the isomérisation of covalent bonds can be catalysed by protein 
disulphide isomerase and peptidyl prolyl cis-trans isomerase. These enzymes do not I
determine the folding pathway but accelerate the slowest steps of the folding process.
I . . . .  I ■ - ,  - ,  ■ ' ■
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1.7.1 Protein Disulphide Isomerase
Protein disulphide isomerase (PDI) is an abundant soluble protein which
catalyses thiol ; di sulphide interchange reactions in protein substrates. This leads to a net 
protein disulphide formation, isomérisation or reduction, depending on the initial I
substrates and imposed thiol : disulphide redox potential. PDI is found within the lumen 
of the endoplasmic reticulum (E.R.) and it has been found that the level of secretory 
protein synthesis of different cell types correlates well with the abundance of PDI 
(Freedman, 1989). In vitro research has shown that the rate of protein folding can be 
increased by PDI. The human chorionic gonadotropin beta subunit (hCG-beta), for
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.example, based on the gel migration of folding intermediates and the order of formation
of six disulphide bonds, has been shown to have indistinguishable in vivo and in vitro 
folding pathways. The same rate-limiting step was found in both environments. 
However, the half time for this step in the cell is 4 min whereas in vitro the half time is 
over 80 min. PDI has been shown to significantly decrease the in vitro half time without 
changing the order of disulphide bond formation (Huth e ta i, 1993).
The mammalian enzyme is a dimer with identical Mr 57 000 subunits, each 
containing duplications of domains which show a strong homology to thioredoxin 
reductase (Edman etal., 1985). Like thioredoxin, the active site of PDI has two 
conserved cysteine residues in the sequence WCGHCK which participate in the thiol : 
di sulphide exchange reactions. The enzyme is identical to the p-subunit of prolyl-4- 
hydroxylase (Pihlajaniemi etal., 1987), an enzyme which causes extensive modification 
of proline residues in nascent collagen molecules. As yet it is unknown whether the 
active site cysteine residues involved in the thiol : di sulphide exchange reaction are also 
involved in the hydroxylation reaction. PDI also shows homology to a surprisingly large 
number of other proteins suggesting that it may have multiple roles concerned with
protein modification and assembly within the E.R.. In addition, PDI is also a component
'il
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1.7.2 Peptidyl prolyl cis-trans isomerase
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.of the microsomal triglyceride transfer protein complex which facilitates the 
incorporation of triglycerides into nascent very low density lipoproteins within the E.R.
(Wetterau etal., 1990).
Interestingly it has been proposed that PDI itself is a chaperone protein, one 
which also contains PDI activity (Wang and Tsou, 1993) John etal. (1993) have shown 
that the ^-subunit of prolyl-4-hydroxylase, which is identical to PDI, is essential for the 
correct folding and assembly of the a2p2 functional complex of prolyl-4-hydroxylase, 
as it prevents the misfolding and aggregation of the a-subunit. As the PDI also forms ;;Â
part of the final functional complex, this chaperone-like function is quite different from
■ ■those already documented. However, the enzyme has also been shown to bind peptides 
which have no obvious sequence similarities to the a-subunit, a property similar to 
chaperone proteins which is discussed in more detail later. The binding by PDI of a 
number of denatured polypeptides and their release only in the presence of ATP (Nigam 
etal., 1994) outlines the intriguing dual action of PDI in vitro which has still to be
confirmed in vivo.
Peptidyl prolyl cis-trans isomerase (PPI) has been shown to catalyse a rate- 
limiting step in in vitro protein folding, the cis-trans isomérisation of proline peptide 
bonds. The efficiency of catalysis of rotation around the X-pro peptide bond by PPI is 
variable and dependent on the target protein. The slow steps of refolding can be 
accelerated rapidly in the case of immunoglobulin light chains (Lang et at., 1987) and 
ribonuclease T1 (Fischer et al., 1989) while more moderate catalysis is observed with 
porcine ribonuclease (Lang etal., 1987) and type III collagen (Bachinger, 1987). Other 
proteins, such as bovine ribonuclease A, show no acceleration of refolding in the 
presence of PPI. Lang etal. (1987) have proposed that the variability observed in the
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.efficiency of catalysis by PPI may be due to the fact that in some cases the Xaa-Pro bond 
is simply inaccessible owing to earlier folding events on the folding pathway creating
7pockets of native tertiary structure.
PPls are highly abundant ubiquitous proteins found in the endoplasmic reticulum 
of all tissues and organisms from bacteria to mammals. The three-dimensional structure 
of two different representatives of the PPI family has been elucidated and this evidence 
supports a 'catalysis by distortion' mechanism (Jaenicke, 1995). As has been suggested 
for PDI, PPI may also have a chaperone-like activity, for example in preventing the 
aggregation of carbonic anhydrase (Freskgard etal., 1992). More direct evidence is
required to fully implicate PPIs as catalysts of protein folding.
1.8 MOLECULAR CHAPERONE PROTEINS
■
The term molecular chaperone was first reported by Laskey etal. (1978) to
describe the function of nucleoplasmin, an acidic nuclear protein that mediates the in
.vitro assembly of nucleosomes from separated histones and DNA but is not a component
of the nucleosome. The term was later extended to describe the postulated roles of a
wider range of different proteins in mediating protein folding and assembly. Molecular
chaperones are now described as a functional class of unrelated families of protein that
mediate the correct non-covalent assembly of other polypeptide-containing structures,
but are not normally components of these assembled structures when the latter are
carrying out their normal biological functions. All of the molecular chaperones studied
to date act not by providing steric information essential for assembly, but by inhibiting
incorrect interactions which would produce non-functional structures and, in some cases,
large insoluble aggregates. Structural homology is seen between members of the same
.chaperone class but not between classes. The major chaperone proteins are briefly 
discussed in the following section with particular emphasis on the prokaryotic
1.8.1 The Nucleoplasmins
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chaperonins groEL and groES and their role in the sequential mechanism of chaperone
proteins.
Nucleoplasmin is a nuclear protein, most abundant in amphibian oocytes where it
can constitute up to 10% of total nuclear protein (Mills etal., 1980). At physiological
ionic strength, nucleosome cores are unable to form in the absence of nucleoplasmin,
resulting from the formation of a precipitate between the basic histones and acidic DNA.
In the presence of a molar excess of nucleoplasmin the strong positive charge of the
histones is shielded by the binding of the chaperone. In this way initial non-specific 
.DNA-histone interactions are prevented allowing the formation of the most energetically
stable conformation, the nucleosome (Laskey etal., 1978). Nucleoplasmin is believed to
be Mg-ATP independent, which distinguishes it from other known chaperone proteins
such as the Hsp 70 and chaperonin 60 classes discussed later. As it has been
demonstrated that under non-physiological conditions, nucleosomes can be reconstituted
.from separated DNA and histones in the absence of nucleoplasmin, by prolonged 
dialysis from high salt concentration (2M NaCl) to lower salt concentrations (Felsenfeld,
1978), it is clear that the chaperone imparts no steric information during its action.
Since the discovery of nucleoplasmin, several homologues have been identified, 
including the nucleolar protein XLNO-38 which is thought to mediate the assembly of 
ribosomes. A family of nucleoplasmin-like proteins may exist which carry out various 
chaperoning functions within the cell (Dingwall and Laskey, 1990). I
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1.8.2 The hsp70 family
The hspTO proteins were initially discovered as proteins whose synthesis was 
increased on heat-shock. They are now recognised as a large, highly conserved group, 
not all of which are heat inducible, found throughout eukaryotic cells. E, coli contains a 
heat-inducible hsp70 called dnaK. DnaK genes in other bacteria have not as yet been 
extensively studied, but most bacteria contain only one (Lund, 1995). In the yeast 
Saccharomyces cerevisiae, however, the situation is far more complex with at least six 
hsp70 homologues in the cytosol (SSA1-SSA4, SSBl and SSB2), the mitochondria 
(SSClp) and in the endoplasmic reticulum (Kar2), (Craig et al., 1993). Studies in other 
eukaryotic cells show that hsp70 proteins can migrate to the nucleus, are present in 
chloroplasts and their presence in other organelles has also been postulated.
Genetic studies show that these proteins are important and sometimes essential 
for cell function. Although E. coli can survive the loss of its dnaK gene, such cells are 
clearly distressed as they only grow at low temperatures and tend to form filaments. 
Overexpression of DnaK has been observed to stimulate the membrane translocation of 
a hybrid protein which is usually unable to cross the inner membrane (Phillips and 
Silhavy, 1990). Strong associations have been observed in mammalian cell lines 
between hsp70 and ribosomes by immunoprécipitation experiments, suggesting that the 
hsp70 is binding to proteins as they emerge from the ribosome to prevent their 
aggregation or misfolding (Beckmann et ai, 1990). The ability of hsp70 to bind to 
unfolded proteins in vitro has led to the suggestion that one of their roles in vivo is the 
protection of partially denatured proteins (Pelham, 1986), although they may also target 
some denatured proteins to the degradative pathways. It has also been demonstrated that 
hsp70s play a role in reactivation of damaged proteins. This was shown with the enzyme 
luciferase, which is rapidly inactivated in E. coli that is heated to 43°C but recovers 
activity on return of the cells to 37°C. This reactivation is substantially reduced in dnaK
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mutant cells, although this is obviously not the only component involved as a reduction 
in recovery of luciferase activity is also observed in cells with mutant dnaj, groEL and 
groES genes (Schroeder eta i, 1993). The dnaj gene was first identified in E. coli 
because mutations in this gene block DNA replication of phage, X. The dnaJ gene is 
located in an operon immediately downstream of dnaK and considerable amino acid 
conservation has been observed between DnaJ proteins from a number or sources, 
particularly in a 70 amino acid section termed the J region (Silver and Way, 1993). It has 
been suggested that certain DnaJ proteins interact with only certain Hsp70s, implying 
that DnaJ, and not solely the peptide-binding pocket of Hsp70, determine substrate 
specificity (Brodsky etal., 1993). Alternatively, Hsp70 could be targeted to a particular 
substrate via cocompartmentalization of certain DnaJs and Hsp70s (e.g. Caplan eta l,
1992; Hattori etal, 1993). Many studies have shown that proteins need to be in an 
unfolded state to cross membranes (Eilers and Schatz 1988), and it seems likely that 
hsp70 homologues on both sides of the membrane maintain protein in this state to enable 
membrane translocation to occur.
Hsp70 proteins have been shown to be involved in protein translocation across 
membranes, protein translation and protection and recovery from heat shock. Other 
roles, such as uncoating of clathrin cages, initiation of DNA replication and sensing the 
temperature of the cell, have also been suggested. Interaction with proteins with DnaJ 
motifs appears to be an important part of at least some of these processes, all of which 
seem likely to stem from the interaction of hsp70 with the unfolded or partially unfolded 
protein. Hsp70 proteins , certainly in the case of BiP, the hsp70 homologue found in the 
endoplasmic reticulum, are believed to exist in an oligomeric form which can be 
mobilised into an active monomeric form on the binding of substrate polypeptides 
(Blond-El guindi etal., 1993), This binding takes place with the C-terminal region of the 
hsp70 protein and is weakened in the presence of hydrolysable ATP (Flynn etal., 1989;
Langer et al., 1992a). Nucleotide binding to the N-terminus causes a conformational
change in the hsp70 protein, as judged by protease susceptibility (Liberek etal., 1991a), 
which is presumably transmitted to the C-termina1 domain, causing the polypeptide to be 
released. Hsp70 chaperones are believed to interact with other proteins in vivo, including 
Dnaj and Gq^E, which help to regulate the chaperones ATPase activity and thus 
polypeptide release (Liberek etal., 1991b).
1.8.3 The Hsp90 family
Another abundant and ubiquitous class of heat-shock proteins which have some 
properties typical of molecular chaperones in vivo are in the 80-90 kDa range, and are 
generally referred to as the hsp90 proteins. Like hsp70s, members of the hsp90 class of 
chaperones are highly conserved in bacteria, yeast and mammals with approximately 
40% identity between the various eukaryotic hsp90s and the E. coli homologue HtpG, 
which is actually a rather diminutive member of this family at 62.5 kDa (Bardwell and 
Craig, 1988). In eukaryotic cells, hsp90s comprise 1-2% of cytoplasmic protein under 
normal conditions, a figure which rises under conditions of stress (Hendrick and Hartl, 
1993). In S. cerevisiae two homologues of hsp90 exist. The first, Hsc82, is constitutively 
expressed while the second, Hsp82, has a low basal level of expression which can be 
induced 10 to 15 fold on heat-shock (Borkovich et ai, 1989). Inactivation of both of 
these genes is lethal at any temperature, although cells can survive single mutations at 
temperatures up to 37.5°C. Studies on HtpG have shown that it helps the cell grow more 
efficiently at high temperature, but it is not essential for growth.
Hsp90s have been found to associate with a variety of other proteins including 
cellular protein kinases and steroid hormone receptors (Gething and Sambrook, 1992) 
where the common role of the hsp90 protein in these cases seems to be in stabilising the 
target protein in a non-native conformation. Hsp90-bound steroid receptors retain a high 
affinity for the steroid hormone but are unable to bind DNA and therefore unable to
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1,8.4 The sHSP family
a
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activate transcription. The displacement of hsp90 from the receptor occurs on steroid 
binding which then enables the steroid/steroid receptor complex to bind DNA and 
activate transcription (Sanchez et ai, 1987). ît has also been shown that hsp90s can aid 
the prevention of aggregation of chemically denatured proteins such as citrate synthase 
and the Fab fragment of a monoclonal antibody providing further evidence of the 
chaperoning properties of this class of proteins (Wiech etaL, 1992).
Nadeau etal. (1993) have shown that members of the hsp90s have ATPase 
activity which can sometimes be stimulated by the binding of substrate proteins. The 
mechanistic role of this stimulation is not yet clear. Hsp90s also undergo slow 
autophosphorylation on serine and threonine residues which has been found to have no 
effect on the ATPase activity but has been suggested that this may regulate the ability of 
hsp90 to bind its protein targets. It appears that hsp90s have a multitude of functions 
conferred by the ability to bind reversibly to proteins with exposed hydrophobic 
surfaces. The interaction of hsp90s with such proteins and with other classes of 
chaperone proteins may well be crucial in the regulation of a wide range of intracellular 
processes.
3j-;-;l
Small heat shock proteins (sHSP) are a conserved group of heat-shock inducible
proteins with molecular masses between 15 and 30 kDa. The sHSPs have been shown to
.be homologues of oc-crystallin, a predominant eye lens protein which is also present in
other tissues, not only at the amino acid sequence level (deJong eta l, 1988) but also on
.a structural level (Merck etal.y 1993). The sHSPs share functional chaperone properties 
with the oc-crystallins in that they prevent misfolding of a variety of thermally and
chemically denatured proteins (Horwitz, 1992; Jakob et al., 1993; Merck et al., 1993).
This reactivation, certainly in the case of both citrate synthase and oc-glucosidase, in the
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presence of either sHSPs or oc-crystallin seems to be independent of ATP (Jacob et ai, 
1993). It remains to be seen whether the sHSPs have specific functions within the cell, 
independent of other chaperone proteins, or whether they act in concert with other 
regulatory proteins in vivo.
1.8.5 The hsp60 family
The hsp60 proteins were the first proteins to be recognised as having chaperone 
function (Hemmingsen etaL, 1988). Like the hsp70 proteins, they are encoded by highly 
conserved genes and are found in all organisms and many cellular locations. This family 
of proteins, also called the chaperonins, includes two types of protein, generally called 
chaperonin 60 and chaperonin 10, or GroEL and GroES in E. coli, the organism on 
which a large proportion of chaperonin research has been carried out (Sabil and Wood, 
1993). GroEL is a heat-shock protein which can be increased from about 1% to 10% of 
the total soluble cytoplasmic protein following cellular stress (Hemmingsen etal., 1988) 
but is essential for eellular growth at all temperatures (Fayet etal., 1989). The groE 
gene, which encodes both groEL and its partner chaperonin groES, was initially 
discovered because mutations in it prevented the growth of several bacteriophages. 
Assembly of the bacteriophage X and T4 head structures and T5 tail structures does not 
proceed in the absence of groEL (Georgopoulos et al., 1972; Georgopoulos etal., 1973; 
Zweig and Cummings, 1973). Hsp60 was first identified in mitochondria in 
Tetmhymena thermophilia as a groEL related stress protein during heat shock conditions 
(McMullen and Hallberg, 1987). Early studies such as these indicated a role in the 
assembly of other proteins and it now seem clear that this is a general function for these 
proteins within the cell. Highly related hsp60 homologues have not been detected in the 
eukaryotic cytosol or the endoplasmic reticulum. However, in the cytosol of many 
organisms including thermophilic archaebacteria, plants and mammals, proteins with
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1.8.5.1 Structure and function of groEL and groES
.:Pweak hsp60 homology have been identified which appear to have chaperonin-like 
functions (Lewis a/., 1992; Trent e/a/., 1991; Yaffe e/a/., 1992; Mummert
1993). This group of proteins, typified originally by the mouse protein called TCPl, 
assemble into a hetero-oligomeric protein complex called TRiC (TCPl ring complex) 
within the cell and are generally referred to as the TRiC family. The TRiC family may 
be regarded as a sub-class of chaperonins which are postulated to carry out groEL-like 
functions within the eukaryotic cytoplasm. As yet no equivalent of the co-chaperonin, 
groES, has been identified for TRiC. It may be that a co-chaperonin is not required, 
since studies comparing the refolding of tubulin by TRiC and the E. coli chaperonins 
demonstrated that TRiC was able to fold tubulin efficiently while groEL was only able 
to do so in the presence of groES (Burston and Clarke, 1995).
!■
GroEL is an oligomeric protein consisting of 14 identical subunits arranged in 2
stacked 7-membered rings with a central cavity, known as the 'double doughnut ' (Hohn
et al., 1979; Hendrix 1979). Each subunit has a molecular mass of 57.3 kDa, giving a
.total molecular mass of over 800 kDa (Hemmingsen et ai, 1988). Electron microscope 
analysis of negatively stained oligomeric groEL has indicated that the overall cylindrical 
shape has a height and diameter of approximately 160 nm and 130 nm respectively (Ishii 
et al., 1992; Langer et al., 1992b). Each subunit consists of three distinct domains. The 
largest of these, the equatorial domain, contains the N-terminal and C-terminal residues 
which from crystallographic data appear to project into the central channel (Braig et al.,
1994). The equatorial domain is highly a-helical and serves as the structural foundation 
providing most of the contacts with adjacent subunits in the ring and in addition contains 
the ATP binding site. The apical domain forms the opening of the central channel and 
possesses a degree of local flexibility enabling a wide range of unfolded polypeptides to
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I"be accommodated. The intermediate domain, as its name suggests, forms the link
■3between the equatorial and apical domains. Flexibility has also been observed en-hloc 
with the intermediate domain acting as a hinge between the two other domains, GroEL i
possesses a weak ATPase activity (kcat G.Ob sec"  ^ per subunit) (Braig et al., 1993) 
which is dependent on the presence of Mg2+ and K+ ions for maximal activity ( Viitanen si
.■ 's
et al., 1990).The crystal structure of groEL complexed to ATP-y-S has been resolved to |
3
2.4 Â, providing additional structural information (Boisvert etal., 1996). Each subunit of 
ATP is observed to bind to a novel pocket, formed from amino acids which are highly 
conserved among chaperonins. Further, conformational shifts in the equatorial domain 
have been identified on ATP binding.
The gro E operon also encodes groES which has a subunit Mr of 10 368 
(Hemmingsen etal., 1988). GroES exists in a homo-oligomeric form composed of seven 
subunits arranged in a ring-like structure 8 nm in diameter with a 2 nm electron dense 
central channel (Chandrasekhar et al, 1986). GroES has been defined as a (co-) 
chaperonin as have its homologues in mitochondria (HsplO) and plastids (cpnlO) which 
have a similar structural arrangement (Hemmingsen et al, 1988). The crystal structure 
of groES has been resolved to 2.8 Â (Hunt eta l, 1996) confirming the domed shape of :Ithe heptamer, the inside surface of which is hydrophilic and highly charged. Each 3|
subunit of groES contains a mobile loop segment which is involved in groEL binding. In 
the crystal structure this loop is disordered in six of the subunits. The single well - 
ordered copy is observed to extend from the bottom outer rim of the groES dome,
'■13suggesting that the cavity within the dome is continuous with the polypeptide binding #
chamber of groEL in the chaperonin complex (Hunt et al, 1996). Crystal structures of 
other members of the cpn 10 family have also revealed a flexible region extending from 
the lower rim of the dome (e.g. cpn 10 from Mycobacterium leprae. Mande et al,
1996a).
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1.8.5.2 Method of groEL and groES action and their role in the sequential 
mechanism of chaperone proteins
Studies indicate that groEL binds one molecule of substrate protein within the 
central cavity in a conformation resembling the molten globule (Martin et aL, 1991; 
Langer eta l, 1992; Braig etaL, 1993; Chen etal., 1994; Hayer-Hartl etal., 1994). 
Protein folding is achieved through cycles of ATP dependent protein release and 
rebinding (Martin etal,, 1991; Weissman etal., 1994). This process is thought to be 
regulated by groES which binds nucleotide-dependently to one end of the groEL 
cylinder, leaving the cavity of one toroid available for the association of substrate 
protein (Martin etal., 1991; Langer eta l, 1992). GroES binding increases the 
cooperativity of the groEL ATPase activity and after ATP hydrolysis, stabilises the 
seven interacting groEL subunits in the ADP-bound state (Martin etal, 1993). GroES 
dissociates after ATP hydrolysis in the uninhibited groEL toroid and its reassociation 
with the substrate bound groEL complex results in ATP-dependent protein release. This 
sequence of events is illustrated in Figure 1.5.
The main stress proteins of E. coli function in an ordered protein-folding 
reaction. First DnaK (hsp70) recognises the nascent peptide chain and cooperates with 
DnaJ in stabilising an intermediate conformational state lacking ordered tertiary 
structure. The protein is then transferred to groEL (hsp60) via GrpE and ATP 
hydrolysis. GroEL then interacts with groES as described above in order to produce the 
native protein. In this way, groEL and groES are the final stage of the protein folding 
mechanism (Langer eta l, 1992a). Homologues of each of the chaperones involved in 
this E. coli sequence exist in mammalian cells where a similar pathway is thought to 
operate.
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Figure 1.5 Model for the groEL-groES assisted folding of polypeptides
1. The groEL-groES complex is favoured under physiological conditions. The 
groEL ring associated with gro ES is stabilised in a high affinity ADP-binding state 
(shown in bold type), the other ring has a lower affinity for ADP. 2. Upon binding of the 
unfolded polypeptide (U), ADP and consequently groES dissociate. 3. ATP binds, 
weakening the interaction between the polypeptide and groEL, and allows groES to 
rebind. Proteins with a low affinity with groEL may be released at this stage. 4. ATP 
hydrolysis releases the bound polypeptide into the central cavity, allowing it to fold. 
Proteins attaining (near) native structure after this cycle are released (N) 5. Generation 
of the ADP state increases the binding affinity of groEL for groES. Polypeptides which 
have still not reached the (near) native state rebind and the reaction cycle continues 
(from step 2.) Between steps 5. and 2. the groEL protein is rotated 180°, with the 
substrate polypeptide remaining bound in the same ring. This model was taken from 
Martin etal, (1993).
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1.9 PROTEIN (RE)FOLDING STUDIES
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Since the refolding experiments on bovine pancreatic ribonuclease (Anfinsen, 
1961), the unfolding by various methods and refolding of a vast number of proteins, 
both monomeric and oligomeric, have been studied. A wide range of physical 
parameters and solvent compounds have been used as denaturing agents including 
GdnHCl, urea, SDS, LiCl, high temperatures, extremes of pH and high hydrostatic 
pressure (Tanford, 1968; Tanford, 1970). The extent to which the native structure is 
perturbed differs widely with the protein being studied, but to a certain extent, 
dénaturants show additive effects. As a result of the structure-function relationship of 
proteins, monitoring biological function represents the most sensitive method of 
following the refolding process. Secondary and tertiary structural probes, and in 
oligomeric proteins, the state of association are also important approaches used to 
characterise the folding process.
It has been adequately demonstrated that the majority of denatured proteins, both 
monomeric and oligomeric, can be renatured to a degree under appropriate conditions 
(Ghèlis and Yon, 1982). In general, a low protein concentration is employed during
I.
renaturation to minimise undesirable side reactions such as aggregation and sulfhydryl 
.oxidation. It has also been found that the addition of ligands, such as substrates of 
enzymes, and even low concentrations of detergents can increase the degree of 
renaturation of a protein (Tandon and Horwitz, 1987; Mendoza etaL, 1991).
Much interest has been shown in the refolding of nuclear encoded mitochondrial 
proteins as it is known that such proteins cross the mitochondrial membranes in an 
unfolded conlbrmation and so folding and, for oligomeric proteins, subsequent 
association, occurs after translocation. The deactivation and reactivation of citrate 
synthase (CS) has been studied by several laboratories (Srere, 1966; Wu and Yang, 
1970; Greenblatt and Sarkissian, 1972; West eta l, 1990; Zhi etaL, 1992). West e/at.
" ■ !• ■
(1990) showed that deactivation of CS in GdnHCl at concentrations less than 1.5M 
caused substantial activity loss. On dilution this loss of activity is completely reversed. 
The loss of activity in GdnHCl occurs at much lower concentrations than changes in 
circular dichroism, fluorescence and exposure of sulphydryl groups, which all occur 
between 1.8M and 3M GdnHCl. This suggests that GdnHCl at low concentration causes 
a change in CS that is more subtle than global unfolding which occurs at higher 
concentrations. Zhi etal. (1992) have studied the reactivation of GdnHCl-denatured CS 
under a variety of conditions. The addition of bovine serum albumin (BSA), 
oxaloacetate (OAA) and glycerol to the renaturation buffer were found to promote 
reactivation. The effect of these substrates was found to be additive with respect to the 
yield of folded CS. The precise mechanism by which BSA, OAA and glycerol promote 
refolding is uncertain. BSA is generally thought to stabilise structures that approach the 
native conformation. The action of glycerol may be similar to that of BSA, as substances 
like polyethylene glycol, which mimics the water exclusion and viscosity effects of 
glycerol, do not enhance renaturation. OAA may bind to a partially formed active site, 
which then acts as a folding nucléation point.
The refolding of denatured CS by the groE system has also been investigated 
(Buchner etal., 1991; Zhi etal., 1992). Folding assistance is demonstrated by groE in 
both these reports, although the conclusions about the essential presence of groES are 
different in the two studies. It is worth noting that while reports of in vitro renaturation 
of proteins with the assistance of only groEL are interesting mechanistically, their 
importance is probably limited owing to the presence of both components of the groE 
system in cellular protein folding.
To date, the groE assisted refolding of relatively few chosen proteins appears to 
have been studied in detail. Some, such as firefly luciferase, have been chosen because 
of the availability of extremely sensitive assay techniques, in this case a luminescence- 
based enzyme assay. Firefly luciferase is also a useful substrate because its spontaneous
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refolding upon dilution from dénaturant is inefficient (Nimmersgern and Hard, 1993).
Other substrates, such as rhodanese were perhaps initially selected because of the 
relative simplicity of a monomeric system (Mendoza etal., 1991). Additionally, some 
substrates have been studied which are capable of folding reversibly under in vitro 
conditions in the absence of additional components, such as enolase (Kubo et ai, 1993), 
lactate dehydrogenase (Badcoe et ai, 1991) and dihydrofolate reductase (Viitanen et ai,
1991). The addition of groEL to these systems which are capable of spontaneous 
refolding has been found to dramatically reduce the yield of refolded protein, showing 
that groEL is recognising an intermediate state of the folding protein. To further the 
understanding of groE-mediated folding, it is important that in future a wider range of 
substrate proteins are employed as it is clear that a large number of proteins in vivo 
associate with the groE system during folding.
The dissociation, unfolding and unassisted renaturation of bovine heart PDC has 
recently been reported (West etal., 1995). The results of this study show that the 
integrity of this complex is perturbed by relatively low levels of GdnHCl which lead to 
dissociation of the El and E3 components from the E2/X complex core. It was found 
that this dissociation leads to loss of the overall activity of the complex without causing 
any major loss of structure of the individual components of the complex. It was further 
reported that the individual components lose secondary and tertiary structure, as
monitored by far-UV CD and protein fluorescence respectively, at higher levels of 
GdnHCl incubation than those at which activity is lost. Also, it was found that the ability 
to regain activity on subsequent dilution of the GdnHCl to 0.03M correlated with the 
integrity of the secondary and tertiary structure. In this respect, the components of 
bovine PDC behave in a manner typical of a number of other imported mitochondrial 
enzymes, such as glutamate dehydrogenase (West and Price, 1988), fumarase (Kelly and #
Price, 1991), citrate synthase (West eta l, 1990) and NAD+-dependent isocitrate 
synthase (Kelly et al., 1993).
.
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bacterial chaperone proteins groEL and groES.
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This thesis details the purification and characterisation of 2-oxoacid
dehydrogenase multienzyme complexes from various sources. The deactivation and
reactivation of the complexes and their component subunits has been studied using a
.variety of techniques to monitor structural and activity changes during these processes. Î
various in vitro refolding environments to be investigated, including the addition of the
E3 from bovine, yeast and bacterial sources has been purified to enable the effect of
■I
CHAPTER 2
MATERIALS AND METHODS
obtained from Sigma Chemical Co., Poole, Dorset, England. 
2.1.2 Enzymes and proteins
Maidstone, Kent.
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2.1 MATERIALS
2.1.1 Chemicals and biochemicals
4
Acrylamide, dithiothreitol (DTT), 2-mercaptoethanol, polyethylene glycol
(PEG), sodium dodecyl sulphate (SDS) and N,N,N^N ^-tetramethylethyiene diamine
were obtained from BDH Chemicals Ltd., Poole, Dorset, England. N,N^-
methylenebisacrylamide and Triton X-100 were obtained from Fisons, Loughborough,
England. Guanidine hydrochloride (GdnHCl) and isopropylthio-(3-D-galactoside were
obtained from Gibco BRL, Paisley, Scotland. Acetyl coenzymeA (acetyl-1- ‘^^ C) was
obtained from Dupont, Belgium. Bactotryptone and yeast extract were obtained from 
.Difco, Detroit, Michigan, U.S.A. All other chemicals were of analytical grade and were
I
Ï 
Z
I  
;
Bovine serum albumin (BSA), yeast PDC and molecular mass markers for gel
.filtration chromatography were obtained from Sigma Chemical Co., Poole, Dorset.
Molecular mass marker proteins for M^ determination by SDS-PAGE were purchased 
from Pharmacia Ltd., Milton Keynes.
2.1.3 Chromatography media
Sephacryl S-200 was obtained from Pharmacia, Milton Keynes,
Buckinghamshire. DEAE-cellulose was obtained from Whatman Biochemicals,
I
II
i
;s| 
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2.1.5 Bacterial strains
2.1.6 Media
Sterilisation was achieved by autoclaving at ISpsi.
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2.1.4 Pre-packed media
Pre-packed Mono Q, Resource Q, alkyl-Superose and Superose 6 columns were 
obtained from Pharmacia and used on a Pharmacia FPLC system.
■3
The bacterial strain E, coli JRG2872 carrying the plasmid pG5501 was used to 
overproduce E. coli PDC (Russell et al, 1992), This IPTG-inducible system 
overexpresses PDC on a ^  promoter.
For overexpression of groEL, the bacterial strain was E. coli DHl carrying the 
plasmid pGT3270. This plasmid contains the groE genes on a 2.1 kb Eco Rl-M/W III 
DNA fragment (McLennan et at., 1993), a gift from Dr. N. F. McLennan, University of 
Edinburgh, Scotland.
Bacterial stocks were prepared by mixing 5 ml of L-broth culture taken after 
overnight growth, with an equal volume of sterile glycerol and stored frozen at -70°C. j '
Luria broth has been used to grow Escherichia coli cells and consists of:- 
Bactotryptone lOg/1
Yeast extract 5g/l 
NaCl lOg/1
a1I
pH measurements were carried out using a CD 620 digital pH meter (Cambridge.
2.2.2 Dialysis
Dialysis was carried out using tubing obtained from Medicell International Ltd., 
London, which was of 6.3 or 14.3 mm diameter depending on the volume to be dialysed. 
The tubing was pre-treated by boiling for 10 min in 2% (w/v) NaHCOg, 1 mM EDTA 
pH 8. Pre-treated tubing was stored in 100% (v/v) ethanol and rinsed thoroughly in 
distilled water before use.
2.2.3 French pressure cell
Cells were broken by 2 passages through an automatic French pressure cell at 95 
MPa (14000 psi internal pressure). The cell was precooled on ice before use (cat. no. 4- 
3398A, American Instruments Company, Silver Spring, Maryland, U.S.A.).
2.2.4 Protein estimation
Protein concentrations were determined by the method of Bradford (1976) with 
BSA as standard.
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I2.2 GENERAL LABORATORY PROCEDURES
2.2.1 Measurement of pH
ij
U.K.) calibrated at room temperature.
!
■t
2.3 PREPARATION OF PDC AND OGDC FROM BOVINE HEART
PDC and OGDC were prepared by initially taking 600g of either fresh beef heart
i
or beef heart stored at -80°C within 3 h of slaughter, from which fat and connective 
tissue had been removed. Cubes of tissue were blended and extracted in 50mM MOPS
Ibuffer, pH 7.0, containing 2.7 mM-EDTA, 3% (v/v) Triton X~100,0.1 mM-DTT, 0.1 mM-PMSF, 0.1 mM-benzamidine/HCl and 0.2% (v/v) anti-foam. After spinning at 
15000g for 20 min, the collected supernatant was adjusted to pH 6.45 with 10% (v/v) 
acetic acid. At this stage the extracts contained assayable amounts of OGDC activity. 
The presence of lactate dehydrogenase made PDC activity difficult to estimate this early 
in the purification. Both complexes were precipitated by the addition of 0.12 vol. of a 
35% (w/v) PEG solution. After stirring on ice for 30 min, the solution was spun at 
30000g for 15 min. Pellets were re suspended in 50 mM-MOPS, pH 6.8, containing 1% 
(v/v) Triton X-100,2.7 mM-EDTA, 0.1 mM-DTT, 0.1 mM-PMSF and 0.1 mM- 
benzamidine by homogenisation with a loose-fitting Teflon-glass homogenizer. This 
extract was adjusted to 13 mM-MgCl2 and 50mM-sodium phosphate, pH 7.0. The pH 
was then again lowered to 6.45 with 10% (v/v) acetic acid before the addition of 0.12 
vol. 35% (w/v) PEG for a second precipitation. The 2-oxoacid dehydrogenase 
complexes were separated by differential precipitation with PEG. Usually between 0.04- 
0.06 vol. 35% (w/v) PEG was required to precipitate 90% of the OGDC activity, OGDC 
was pelleted by spinning at 40000g for 10 min prior to overnight re suspension in a 
minimal volume of 50 mM-MOPS buffer, pH 7.0, containing 1% (v/v) Triton X-100, 2.7 
mM EDTA, 0.1 mM-DTT, 0.1 mM-PMSF and 0.1-mM benzamidine. The PDC 
containing supernatant fraction was concentrated by centrifugation for 2.5 h at 150000g 
in a Beckman Ti70 rotor. The pellets were re suspended in the same buffer as the 
OGDC. Both complexes were stored at a final concentration of 5-10 mg/ml at 4°C or in 
50% (v/v) glycerol at -20°C.
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experimentally.
2.5 PREPARATION OF PDC FROM Escherichia coli
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2.4 PREPARATION OF E3 FROM BOVINE HEART OGDC
The method for mammalian E3 purification was developed by Ms. Saiqa Khan,
Division of Biochemistry and Molecular Biology, University of Glasgow. NaCl was
3added to the purified complex to 2M giving a protein concentration of -^ 3 mg/ml. This 
solution was incubated on ice for 15 min to allow adequate time for component 
dissociation. A further incubation at 65°C for 10 min then followed, which induced 
dénaturation and aggregation of the less stable complex components. Centrifugation was 
then carried out at 15000g for 10 min to pellet the insoluble aggregates. The E3
remained in the supernatant and was dialysed to remove salt before using
E. coli strain JRG 2872, kindly donated by Prof. J. R. Guest, University of 
Sheffield, overexpresses PDC from a ^  promoter (Russell, et at., 1992). Cultures (250 
ml) in Luria broth containing glucose (0.2% w/v) and ampicillin (50/<g/ml) were grown 
at 37°C with vigorous shaking to mid-exponential phase (A^so^O 25-0.50) and induced 
by the addition of IPTG to 60jaM. After 6-8 h, cells were harvested, washed in buffer 1 
[20 mM-potassium phosphate, pH 7.8, containing 2 mM-Na2EDTA, 1 mM- 
benzamidine/HCl and 1 mM-PMSF] and disrupted using a French pressure cell in the 
same buffer, as detailed in section 2.2.3. The crude extracts were clarified by 
centrifugation at 150000g for 30 min. PDC was sedimented by further centrifugation at 
150000g for 4h. The PDC containing pellet was re suspended in buffer 1 and further 
purified by FPLC ion-exchange chromatography using a Resource Q column with a 0- 
700 mM-NaCl gradient in buffer 1. Fractions containing PDC were pooled and
' -
concentrated by sedimentation as before. Purified complexes were stored in buffer 1 plus
glycerol (50% v/v) at -20°C.
2.6 PREPARATION OF E3 FROM BACTERIAL PDC
2.7 PREPARATION OF GroEL
3 ’
Bacterial E3 was purified from two stages of the whole complex preparation. The 
supernatant from the final high speed spin was found to contain large amounts of E3 
(28-40% of total yield). This was purified using an adaptation of the method described 
in section 2.4. NaCl was added to the supernatant to a final concentration of 2M and 
then incubated at 65°C for 20-30 min. Again the sample was spun for 10 min at 15000g 
and the salt removed by dialysis into the appropriate buffer before using experimentally. 
Secondly, a small amount (3-7% of total yield) of E3 was located in a peak from the 
Resource Q salt gradient, the final step in the bacterial PDC purification process. Heat 
treatment was carried out on the pooled fractions from this peak to further purify if 
required.
'•'A
i
The groEL purification protocol described below was based on adaptations, 
obtained from Dr. G. J. Thomson, to the procedure described previously (Hendrix, 1979; 
Chandresekhar, 1986). Solutions throughout the preparation were kept at 4°C. GroEL 
could not be assayed as the ATPase activity is too weak, so a Phastgel system was used 
to identify groEL containing fractions. The bacterial strain used was E. coli DHl 
carrying the plasmid pGT3270 containing the groE genes on a 2.1 kb Eco REHindlll 
DNA fragment, kindly donated by Dr. N. F. McLennan, ICMB, University of 
Edinburgh, Scotland, UK (McLennan etal., 1993). Bacterial stocks were stored at -70°C 
in 50% (v/v) glycerol. The E. coli were grown on Luria broth containing glucose (0.1%
■
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w/v) until the cell suspension had reached saturation (OD^OO of approximately 5) before 
harvesting the cells by centrifugation (4500g for 15 min). Cells could be used 
immediately or stored in pellet form at -20°C until use, the latter option aiding the next 
step in the purification process. Around 20g of wet weight cells were obtained from a 
typical 41 culture. Cells were re suspended in extraction buffer (50mM Tris-HCl buffer, 
pH 8.0, 5 mM 2-mercaptoethanol, 1 mM PMSF, 1 mM benzamidine) and broken using a 
French pressure cell as detailed previously. Cell wall debris was then removed by 
centrifugation at 15000g for 40 min. Following cell breakage an equal volume of 
streptomycin sulphate (0.05 mg/ml) was added to the supernatant which was stirred on 
ice for 1 h. The extract was then centrifuged for 45 min at 25000g. At this stage the 
solution was gradually brought to 55% (w/v) saturation by addition of solid (NH4)2S04 
and, after stirring for 1 h on ice, the precipitated protein was collected by centrifugation 
at 30000g for 30 min. Precipitated protein was resuspended in 4 ml of S-200 buffer 
(50mM Tris-HCl, pH 8.0, containing 5 mM EDTA, 10% (w/v) glycerol, 5 mM 2- 
mercaptoethanol, IM KCl and 0.5% (w/v) Triton X-100) and loaded onto a Sephacryl S- 
200 column (120 cm x 3 cm) equilibrated in the same buffer. GroEL containing 
fractions, eluting in the void volume of the column, were pooled and dialysed against 
Mono Q 10/10 buffer (20 mM Tris-HCl, pH 7.5, containing 5 mM EDTA). The dialysed 
solution was applied to the anion exchange column and eluted with a 25 ml 0-1M linear 
NaCl gradient in the above buffer. Fractions containing groEL were pooled and dialysed 
against Alkyl-Superose buffer (50mM potassium phosphate pH 7.0, containing 1.5M 
(NH4)2S04). This was then loaded onto an Alkyl-Superose HR 5/5 hydrophobic 
interaction chromatography column equilibrated in the above buffer. GroEL was eluted 
with a linear 1.5-OM (NH4)2S04 gradient.
I
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2.8 STORAGE OF PURIFIED PROTEIN
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Purified mammalian OGDC, bacterial PDC and groEL were dialysed against 100 
volumes of 50mM Tris-HCl, pH 7.6, containing 50% (v/v) glycerol and stored at -20°C.
2.9 DENATURATION CONDITIONS
IThe unfolding of the complexes and purified components was studied in 50mM- potassium phosphate pH 7.6. Solutions of protein (final concentration 0.5-1.0 mg/ml) 
were incubated in the presence of varying concentrations of GdnHCl for 15 min at 4°C 
before measurements of catalytic activity, CD or fluorescence were taken. There was no 
further significant change on incubation for a further 45 min.
2.10 PREPARATION OF DIHYDROLIPOAMIDE
Dihydrolipoamide was prepared from the oxidised form of DL-6,8-thioctic acid 
amide (DL-Iipoamide). 60 mg of DL-lipoamide was dissolved in 1.2 ml of 50% (v/v)
_ethanol in IM potassium phosphate buffer pH 8, to which 2.4 mg of freshly prepared 5%
(w/v) NaBH4 was added for 10 min. This was then neutralised with 1.2 ml of 3M HCl.
The dihydrolipoamide was extracted into the upper solvent layer by adding 3 x 3 ml 
volumes of toluene. Evaporation of the toluene under N2 left crystalline 
dihydrolipoamide which was stored at -20°C until use (Kochi and Kikuchi, 1976).
I
I
2.11 ENZYME ASSAYS
2.11.1 2-oxoacid dehydrogenase complexes
2.11.2 2-oxoacid dehydrogenase (El)
53
The whole complex activities of PDC and OGDC were assayed 
spectrophotometrically at 340nm, as the rate of formation of NADH, at 30°C (Danson et 
al., 1978). Approximately 2-5/ig of complex were assayed in the presence of 670/d 
Solution A (SOmM potassium phosphate, pH 7.6, containing 3 mM NAD+, 2 mM 
MgCl2 and 0.2 mM ThDP), 14/il Solution B (0.13M cysteine-HCl, 0.13 mM 
Li2CoASH) and 14/d Solution C (100 mM pyruvic acid/2-oxoglutarate for PDC and 
OGDC respectively). The above assay solution was preincubated at 30°C and the 
reaction initiated by the addition of enzyme.
The activity of the El component, pyruvate dehydrogenase in PDC and 2~ 
oxoglutarate dehydrogenase in OGDC, was measured by following the reduction of 2,6- 
dichlorophenol-indophenol (DCPIP) at 600 nm. The protein was first incubated at 30°C 
in solution A (as described in the previous section) and DCPIP. The reaction was then 
initiated by the addition of the appropriate solution C (as described in the previous 
section) (Khailova et al, 1976).
Ia
Ia
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2.11.3 Dihydrolipoamide acetyltransferase (E2)
The activity E. coli E2 was measured isotopically via the conversion of 11- 
acetyl-CoA to the radiolabelled S-acetyl dihydrolipoamide intermediate which is 
extracted into toluene, leaving the unreacted [1- acetyl-CoA in the aqueous phase 
(Butterworth etal., 1974). The reaction mixture contained O.l ml of 50 mM potassium 
phosphate, pH 7.4, containing 5 mM cysteine and various amounts of GdnHCl, 10 pi of 
10 mM dihydrolipoamide in ethanol, 20 pi of 2.5 mM of mixed cold acetyl-CoA and [ 1 - 
I'^C] acetyi-CoA, giving a specific activity of 3 x 10^ cpm/pmol. 5-10 pg of PDC and 
water made the total volume of the reaction mixture 0.2 ml. The reaction was started by 
the addition of the acetyl-CoA mixture and incubated at 25°C for 2 min. At this stage the 
reaction was stopped by adding 0.5 ml of toluene and the mixture shaken for 10 s on a 
Vortex mixer to extract the radioactive S-acetyldihydrolipoamide. An aliquot (0.1 mi) of 
the toluene layer was then withdrawn and radioactivity measured in a Beckman liquid 
scintillation spectrometer. Controls were also carried out from which enzyme (or 
dihydrolipoamide) was omitted. This background reading, typically around 40 cpm, was 
subtracted from the experimental readings.
I
2.11,4 Dihydrolipoamide dehydrogenase (E3)
Assays were performed using the method of Jackman et al. (1990) at 30°C. The 
assay buffer used was 50 mM-potassium phosphate, pH 7.6, containing 3 mM-NAD^ I 
mM MgCl2, 0.2mM ThDP and 24pg of dihydrolipoamide (for preparation see section
2.10). The reaction was initiated by the addition of enzyme and the activity followed by
.
monitoring NADH formation at 340nm.
I
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2.12 ATPase ACTIVITY OF GroEL
The ATPase activity of groEL was measured spectrophotometrically by coupling 
the hydrolysis of ATP to the oxidation of NADH by the coupling enzymes pyruvate 
kinase and lactate dehydrogenase. Assays were performed in 50 mM triethanolamine 
buffer pH 8.0 containing 10 mM magnesium acetate. Concentrations of substrates and 
coupling enzymes in the buffer were; 0.5 mM ATP, 1.0 mM phospho^rtt?/ pyruvate, 0.15 
mM NADH, 25 pg/ml pyruvate kinase and 8.3 pg/ml lactate dehydrogenase. The 
oxidation of NADH was monitored at 340 nm (Price et al, 1993).
i
2.13 SDS POLYACRYLAMIDE GEL ELECTROPHORESIS
I
Electrophoresis in the presence of SDS was performed using the method of 
Laemmii (1970), with a 3% stacking gel and a 10% or 12% running gel. The ratio of 
acrylamide : bisacrylamide was 30 : 0.8 for each gel. Polymerisation was induced by the
I
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addition of 0.03% (v/v) TEMED and 0.05% (w/v) ammonium persulphate. After 
electrophoresis, protein on the gels was visualised by staining with Coomassie blue for 
at least 90 min at room temperature whilst rotating at slow speed on a shaker. The 
Coomassie reagent was 0.1% (w/v) Coomasie Brilliant Blue G250 in 50% (v/v) 
methanol and 10% (v/v) glacial acetic acid. Destaining was carried out in 10% (v/v) 
methanol and 10% (v/v) glacial acetic acid, the destain being replaced at intervals until 
the background was fully destained and bands clearly visible.
2.14 CIRCULAR DICHROISM
Circular dichroism (CD) is a spectroscopic property which is sensitive to 
molecular conformation, and thus is widely used in the study of protein structure. The
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near-ultraviolet (UV) CD bands of proteins (340-250 nm) are principally due to 
tryptophan, tyrosine, phenylalanine and cystinyl groups, and they reflect the tertiary and 
quaternary structure of the protein. The far-UV CD bands of proteins (260-178 nm) 
derive from the amide chromophore and reflect the secondary structure of the protein 
(a-helix, ^-sheet etc.). For most proteins the native state has a much more intense CD 
spectra over most of the far- and near-UV wavelength. The large loss of intensity which 
occurs in both of the wavelength regions upon treatment of the protein with a 
dénaturant, such as GdnHCl, combined with fluorescence measurements, allow the 
stability of tertiary and secondary structure to be compared.
CD spectra were recorded at 20°C on a JASCO J-600 spectropolarimeter. All 
spectra were recorded by Dr. Sharon Kelly, Department of Biological and Molecular 
Sciences, University of Stirling.
2.15 FLUORESCENCE
Fluorescence spectroscopy is a sensitive technique which can be employed 
continuously or discontinuously to obtain information on protein tertiary structure 
around fluorogenic amino acids. Fluorescence emission is observed on the return to the 
ground state of an excited electron. Nonfluorescent compounds lose the energy of the 
excited molecule as heat, while fluorescent compounds emit part of this energy as light. 
Due to the energy loss, the fluorescence emission is shifted to a longer wavelength 
compared to that of excitation. In the fluorescence experiments shown in Chapter 5, the 
excitation wavelength is 290 nm and emission has been monitored either by scanning 
from 310 nm to 400 nm, or at 340nm each second over 5 min to follow the tertiary 
structural changes during protein refolding.
Fluorescence changes were recorded at 25°C on a Perkin Elmer LS50 
spectrofluorimeter with slit width setting at 5.0.
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2.16 LIGHT SCATTERING MEASUREMENTS
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Light scattering is a useful tool in following the association and dissociation of
. :
subunits of multimeric proteins. It has the advantage over other methods that 
measurements can be made very rapidly. The protein solution is illuminated with a beam 
of light with a wavelength far from any absorption band in the solvent or the protein.
The amount of light scattered in directions other than that of the incident beam is 
proportional to the Mr of the protein in solution. Subunit association or aggregation can 
therefore be detected by an increase in intensity of scattered light over time.
Light scattering experiments were carried out at 25“ C using a Perkin Elmer LS50 
spectrofluorimeter. The illuminating wavelength was 350 nm. Detection of scattered 
light (350 nm) was at 90“ to the incident beam. Slit width setting was 2.5.
CHAPTER 3
PURIFICATION AND INVESTIGATION OF THE 2-0X 0ACID 
DEHYDROGENASE COMPLEXES
,3.1 Introduction
:
The effect of structural changes on the activity of enzymes has been widely
studied. Changes in primary structure aside, chaotropes such as urea and GdnHCl have
been instrumental in enabling detailed information to be collected on the unfolding and
.subsequent renaturation processes. Comparison of the unfolding and inactivation of 
several enzymes in the presence of GdnHCl and urea have suggested that the active sites
are usually situated in a limited region of the enzyme molecule that is more susceptible 
to dénaturants than the protein as a whole (Tsou, 1986). It has been noted that different 
chaotropes do not necessarily produce the same end product. The dimeric pig heart 
citrate synthase, for example, is dissociated into monomers on treatment with GdnHCl 
but remains dimeric when incubated with a comparable concentration of urea (Wu and 
Yang, 1970). Subtle differences exist, therefore, in the mechanism of action these 
reagents in disrupting non-covalent interactions both within and between polypeptide 
chains. Previous work (West et al., 1990) has suggested that GdnHCl denatures 
multienzyme complexes in three steps. Initially, subunit dissociation occurs at low 
GdnHCl concentrations. This is followed by local perturbation of the active site of 
individual components of the complex at intermediate GdnHCl concentrations. Beyond 
this secondary and tertiary structural changes occur progressively with increasing 
dénaturant concentrations. Throughout this investigation GdnHCl has been employed, 
primarily to enable this work to be usefully compared to that of West et al. (1995).
:#
This chapter deals with the purification and characterisation of OGDC and PDC 
from bovine heart and PDC from E. coli strain JRG 2872. Purification was followed by 
assay of intact complex activity, monitoring NADH formation spectrophotometrically at
'
340nm, and by SDS-PAGE. Initial characterisation of the complexes was carried out
.using GdnHCl-induced unfolding and subsequent refolding which was again monitored
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using the intact complex. Also, circular dichroism has been employed to monitor 
secondary structural changes resulting from GdnHCl-induced dénaturation.
3.2 OGDC and PDC purification from bovine heart
OGDC and PDC were purified from bovine heart as described in the Materials 
and Methods section. This protocol is based on that of Stanley and Perham (1980), with 
adaptations, outlined by De Marcucci et al. (1985). The same preparation can be used to 
purify both complexes although the amount of PEG used in the final cut is an important 
factor in the purity of the complex. Throughout the procedure estimates of protein 
concentration were made using the Bradford assay. Whole complex activity was also 
monitored. A typical set of data for the OGDC purification procedure is shown in Table 
3.1. Purification was also followed by SDS-PAGE. Figure 3.1 shows samples taken 
from an OGDC preparation at the same stages as are shown in Table 3.1.
In this way both complexes were obtained with specific activities of 3-5 units/mg 
when assayed at 25°C. The extent of cross-contamination was estimated to be less than 
1% on the basis of activity measurements.
3.3 Loss of activities of PDC and OGDC from bovine heart
The loss of activity of the complexes when incubated with and assayed in the 
presence of increasing GdnHCl concentrations is illustrated in Figure 3.2A. From this 
graph it can be seen that both complexes have lost all activity after incubation in 0.3M 
GdnHCl. OGDC activity is reduced to 50% of its original value at 0.1 IM GdnHCl 
whereas for PDC this value is 0.07M.
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Figure 3.1 SDS-PAGE analysis of samples taken during trypic digestion of purified 
bovine heart OGDC
OGDC was resolved on 10% SDS-PAGE and stained with Coomassie blue. Lane 
M, low Mr proteins (10 pig); lanes 1 to 6, 15 pig samples taken at the same stages of the 
preparation as are shown in Table 3.1.
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3.4 Reactivation of beef heart OGDC and PDC by dilution of GdnHCl
.The results of experiments in which either OGDC or PDC were incubated in 
GdnHCl for 15 min at 4°C, and then diluted into buffer for assay so as to lower the 
residual GdnHCl concentration to below 0.03M, are shown in Figure 3.2B. It is clear 
that the ability of PDC to regain complex activity decreases dramatically when the initial 
GdnHCl concentration is above 0.7M and is lost completely after pre-exposure to
■ " Iconcentrations above 1.8M. OGDC can be seen to be more sensitive to GdnHCl
incubation as its ability to regain complex activity decreases rapidly when it is incubated
.above 0.3Nt. For OGDC 50% of activity is regained after dilution from 0.5M GdnHCl 
incubation, a concentration at which PDC regains all of its activity.
3.5 PDC purification from E. coli
3.6 Loss of activity and subsequent reactivation of E. coli PDC
PDC was purified from E. coli strain JRG 2872 using the procedure reported by 
Russell etal. (1992), with minor adaptations which are outlined in Materials and 
Methods. Throughout the procedure estimates of protein concentration were made using 
the Bradford assay. Whole complex activity was also monitored as described previously. 
A typical set of data for the purification procedure is shown in Table 3.2. Purification 
was also followed using SDS-PAGE. Figure 3.3 shows samples taken from an PDC 
preparation at the same stages as are shown in Table 3.2.
Ï
iI
The loss of intact complex activity was monitored after incubation with GdnHCl 
for 15 min at 4°C. The results are shown in Figure 3.4. Comparing Figure 3.4 with 
Figure 3.2 it can be seen that the reversible nature of inhibition of bovine PDC by
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Figure 3.2 Inactivation and reactivation of bovine heart PDC and OGDC
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Enzyme complexes were incubated at4“C in 50mM potassium phosphate, pH
7.6 containing GdnHCl for 15 min before the extent of inhibition (shown in A where 
assay mixture contained the same [GdnHCl] as incubation) or reactivation (shown in B 
where [GdnHCl] is reduced to below 0.03M by dilution) was assayed. The 
concentrations of PDC (■) and OGDC (#) were both I mg/ml. In each case the changes 
are expressed relative to control sample from which GdnHCl was omitted. Results 
shown are averages of 3 readings taken from different preparations.
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Figure 3.3 SDS-PAGE analysis of samples taken throughout the E. coli PDC 
purification process
Samples from the various stages of the E. coli PDC preparation stated below 
were diluted to approximately 0.5 mg/ml and \5 pi\ of each was mixed with an equal 
volume of Laemmli sample buffer and resolved on a 10% (w/v) SDS-polyacrylamide 
gel. Lane I-homogenate, lane 2- after clarification spin, lane 3- resuspended pellet after 
4 h ultracentrifuge step, lane 4- supernatant after 4 h ultracentrifuge step, lane 5- 
resuspended pellet after filtering and lane 6- after Resource Q column step.
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Figure 3.4 Inactivation and reactivation of bacterial PDC
PDC was incubated at 4°C in 50mM potassium phosphate, pH 7.6 containing 
GdnHCl for 15 min before the extent of inhibition (A, with assay mixture containing the 
same GdnHCl concentration) or reactivation (A, GdnHCl concentration reduced to 
below 0.03M by dilution) was assayed. In each case the changes are expressed relative 
to control sample from which GdnHCl was omitted. Results shown are averages of 3 
readings taken from different preparations.
6 8
i
i
GdnHCl is lost as the concentration of dénaturant is increased above 0.7M and this 
ability is completely lost when incubated at GdnHCl concentrations above 1.5M. The E. 
coli PDC loss of re activation range is from 0.9-2.0M, with 38% re activation occurring 
after incubation in 1.6M GdnHCl, conditions from which the bovine complexes show no 
significant recovery of activity. Thus, it can be seen then that the bacterial complex is 
the most resilient of those studied to incubation in GdnHCl.
3.7 Unfolding of bovine heart OGDC and PDC and E. coli PDC as monitored by 
changes in CD properties
Figure 3.5 (A, B and C) shows the far-uv CD spectra of beef heart OGDC (A) 
and PDC (B) and E. coli PDC (C). The results are shown in Figure 3,6 in terms of the 
changes of ellipticity at 225nm relative to the total changes occurring between 0 and 6M 
GdnHCl. Figure 3.6 presents the ellipticity data for the three complexes together and 
from this it can be seen that the OGDC and PDC from the same source behave in a very 
similar fashion when incubated in GdnHCl with the majority of secondary structure 
being lost at GdnHCl concentrations above 4M. PDC from E. coli can be seen to be 
more resistant to secondary structural changes when incubated in low levels of GdnHCl 
(0-1,5 M) than the bovine complexes. However, at incubations above 2.0 M GdnHCl the 
three complexes studied show little difference in the pattern of loss of secondary 
structure.
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Figure 3.5A Changes in the far-UV CD spectra on dénaturation of bovine heart
OGDC with GdnHCl
Spectra were obtained in 50mM potassium phosphate buffer, pH 7.6 at 20°C. 
Unfolding of OGDC (90/rg/ml) was carried out in the presence of GdnHCl for 15 min at 
4°C. Spectra were recorded by Sharon Kelly in the laboratory of Prof. Nicholas Price at 
Stirling University.
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Figure 3.5B Changes in the far-UV CD spectra on dénaturation of bovine heart
PDC with GdnHCl
Spectra were obtained in 50 mM potassium phosphate buffer, pH 7.6, at 20°C. 
Unfolding of PDC (80/fg/ml) was carried out in the presence of GdnHCl for 15 min at 
4°C. Spectra were recorded by Sharon Kelly in the laboratory of Prof. Nicholas Price at 
Stirling University.
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Figure 3.5C Changes in the far-UV CD spectra on dénaturation of E. coli PDC with
GdnHCl
Spectra were obtained in 50 mM potassium phosphate buffer, pH 7.6, at 20°C. 
Unfolding of PDC (80//g/ml) was carried out in the presence of GdnHCl for 15 min at 
4°C. Spectra were recorded by Sharon Kelly in the laboratory of Prof. Nicholas Price at 
Stirling University.
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Figure 3.6 Comparing the GdnHCl induced unfolding of E. coli PDC, bovine heart 
PDC and OGDC using circular dichroism I
The data shown in Figures 3.5A and 3.5B have been used to calculated the 
percentage of the total change occurring between 0 and 6M GdnHCl incubations. 
Ellipticity of E, coli PDC (A), bovine heart PDC (■) and OGDC (#) were measured at 
225nm. I
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3.8 Discussion
This chapter describes the purification and basic characterisation of E. cnli PDC 
and bovine heart OGDC and PDC complexes. The E. coli PDC purification (detailed in 
Table 3.2 and Figure 3.3) provided a reproducible method for PDC overproduction with 
around 30% recovery. It has previously been shown that PDC purified using this method 
has an excess of E3 subunits and a reduced amount of El subunits and it is thought that 
hyper production of E3 may limit the extent of El binding (Russell etal, 1992). As can 
be seen from Figure 3.3, PDC forms a major part of the original homogenate. Two of the 
contaminating polypeptides whose Mr are between those of the El and E3 subunits can 
be seen in Figure 3.3 in lanes 3 and 4. The upper band (lane 4) has been shown to be 
lysine decarboxylase. The lower band (lane 3) was first thought to be a proteolytic 
fragment of El because a tryptic fragment of this subunit migrates with approximately 
the same mobility (Russell and Guest, 1990). However, sequencing has shown that this 
lower band is identical to the chaperonin, GroEL, over 30 residues (Russell et al, 1992). 
The presence of GroEL is interesting as it has been implicated in the folding of many 
proteins and is investigated further in Chapter 5, However, it is unclear whether its 
appearance here is due to the increased number of PDC molecules requiring folding 
assistance or stress that may be caused by the addition of ÏPTG.
The E. coli PDC unfolding and renaturation after GdnHCl incubation is shown in 
Figure 3.4. From this it can be seen that the complex activity is perturbed by relatively 
low levels of GdnHCl (in the range 0-0.3M). The ability to regain activity on dilution 
from GdnHCl is lost gradually after incubation in GdnHCl solutions between 0.9-2.0M. 
This shows that while PDC activity can be recovered after its total loss during GdnHCl 
incubation, refolding from a totally unfolded state is not possible under these conditions. 
Bovine OGDC and PDC both behave similarly to the E. coli PDC on incubation in 
GdnHCl, with activity being lost in the range 0 0.3M, again relatively low levels (Figure
77
3.2A). For bovine PDC it has been demonstrated that this loss of activity is due to the 
dissociation of the El and E3 components from the E2/X core (West ef al., 1995). As 
this dissociation occurs in full at O.IM GdnHCl, it is clear that on dilution spontaneous 
reassociation of the subunits occurs. Both bovine complexes appear to be less resilient to 
dilution from GdnHCl incubation (Figure 3.2B). It is clear from Figure 3.6 that only a 
small percentage of the total secondary structural change has taken place after 
incubation of bovine OGDC and PDC in l.OM GdnHCl. It appears that after around 
15% of total secondary structure has been lost during GdnHCl incubation, activity can 
not be recovered on dilution. This loss of complex activity may be due to the misfolding 
of one of the subunits causing its lack of activity and thus inactivity of the whole 
complex. The unfolding and reactivation of the individual subunits of each of the 
complexes is investigated in detail in Chapter 4.
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CHAPTER 4
INVESTIGATION OF THE COMPONENT ENZYMES
i
■i
4.1 Introduction
Following the unfolding and reactivation of OGDC and PDC by monitoring the 
effects of GdnHCl on overall complex activity and CD and fluorescence properties gives 
an overview of the effects on the individual components. Since the individual folded 
chains might be expected to expose more hydrophobic side-chains prior to association, it 
seems reasonable to assume that a multi-subunit assembly is likely to lead to 
stabilisation of each subunit. Other features such as loops which might offer a suitable 
target for proteolysis in vivo may also be concealed during the association process 
adding to the increased stability. Although in some cases dissociation precedes 
unfolding, quantitative data on the increased stability afforded by association are in other 
cases difficult to obtain because conditions promoting dissociation can lead to partial 
unfolding of the subunits themselves, particularly where tightly associated subunits, 
such as the bovine OGDC El and E2 components, are concerned. Work by Chan and 
Mosbach (1976) is in general agreement with the assumption made above. This has 
shown that single matrix-bound subunits are more susceptible to dénaturation than the 
same subunit assayed within the oligomeric complex, although the possibility that the 
matrix environment is complicating the interpretation of the results cannot be excluded. 
The 2-oxoacid dehydrogenase multienzyme complexes provide an interesting model to 
investigate this association stabilisation as the individual components can be assayed in 
the presence or absence of the rest of the complex.
In this chapter the stability of the individual components of the complexes are 
studied. The results for the component enzymes are compared between complexes. 
Isolation of E3 from various sources has been carried out to enable comparison of its 
deactivation and reactivation as free enzyme or in the intact complex. Results in this
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chapter are obtained using assays of the individual components of the complex and by 
monitoring CD and fluorescence changes after incubation in the presence of dénaturant.
4.2 Unfolding and reactivation of the El component
over the range 0.6-2. IM GdnHCl.
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A clearer picture of the unfolding events which occur during whole complex 
inactivation can be obtained by monitoring the loss and regain of activity of the 
individual components of the complex upon treatment with dénaturant and subsequent 
dilution. Figure 4.1 shows the effects of GdnHCl treatment where the activity of 
complex-bound El from bovine heart OGDC is monitored. It can be seen that 98% of 
El activity is lost after incubation and assaying in 1 .OM GdnHCl. The ability to regain 
activity is progressively lost over the range 0.8-2.2M GdnHCl. The unfolding and
reactivation of El isolated from bovine heart PDC is shown in Figure 4.2. It has been
shown previously that there is no significant difference between unfolding and 
reactivation experiments performed on isolated and complex intact bovine PDC El (S. 
M, West, unpublished work). From Figure 4.2 it can be seen that all El activity is lost 
after incubation and assaying in l.OM GdnHCl and that reactivation upon dilution of 
dénaturant decreases progressively between 0.8 and 1.6M. Figure 4.3 shows similar data 
for PDC El from E. coli. El from this source appears to be marginally more sensitive to 
GdnHCl inactivation with no activity remaining after incubation and assaying in 0.75M 
GdnHCl. The ability to regain activity after incubation is progressively lost in this case
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Figure 4.1 Deactivation and reactivation of bovine heart OGDC E l
Bovine heart OGDC (1 mg/ml) was incubated at 4“C in 50mM potassium 
phosphate, pH 7.6 containing GdnHCl for 15 min before the extent of inhibition (with 
assay mixture containing the same GdnHCl concentration, ■ ) or reactivation (GdnHCl 
concentration reduced to below 0.03M by dilution, □) was assayed for El activity as 
outlined in Materials and Methods. In each case the changes are expressed relative to 
control sample from which GdnHCl was omitted. Results shown are averages of 3 
readings taken from different preparations differing by no more than plus or minus 5%.
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Figure 4.2 Deactivation and reactivation of bovine heart PDC El
El was isolated from bovine heart PDC and was incubated at 1 mg/ml at 4°C in 
50mM potassium phosphate, pH 7.6 containing GdnHCl for 15 min before the extent of 
inhibition (with assay mixture containing the same GdnHCl concentration, ■) or 
reactivation (GdnHCl concentration reduced to below 0.03M by dilution, □) was 
assayed for El activity as outlined in Materials and Methods. In each case the changes 
are expressed relative to control sample from which GdnHCl was omitted. Results 
shown are averages of 3 readings taken from different preparations differing by no more 
than plus or minus 5%. These data are in agreement with those of West etal. (1995).
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Figure 4.3 Deactivation and reactivation of E. coli PDC El
E. coli PDC (1 mg/ml) was incubated at 4°C in 50mM potassium phosphate, pH
7.6 containing GdnHCl for 15 min before the extent of inhibition (with assay mixture 
containing the same GdnHCl concentration, A) or reactivation (GdnHCl concentration 
reduced to below 0.03M by dilution, A) was assayed for El activity as outlined in 
Materials and Methods. In each case the changes are expressed relative to control 
sample from which GdnHCl was omitted. Results shown are averages of 3 readings 
taken from different preparations differing by no more than plus or minus 5%.
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4.3 Tryptic digestion of bovine OGDC
E2 core and conduct similar unfolding and reactivation experiments to those shown in
4.4 Unfolding and reactivation of E l
To investigate whether the other complex components are contributing to the 
stability of the bovine OGDC El component it was necessary to dissociate El from the
Figure 4.1. As the E l and E2 components of OGDC are tightly associated and there is
no published procedure to date to separate these components without dénaturation, a
proteolytic method was employed. Low levels of trypsin have been shown to promote a
rapid, highly-selective cleavage of El as can be seen in Figure 4.4. This cleavage
,produces a large stable, 100 000 Mr fragment, designated E l , and a small peptide with 
an estimated Mr value of 10 000 which is not detected in the gel system used in Figure
■4.4. Previous work has shown that the cleaved N-terminal region of bovine OGDC El
exhibits significant sequence similarity with corresponding sequences from the lipoyl 
domains of the E2 and protein X components of eukaryotic PDCs, (Rice et aL, 1992). 
This region of bovine OGDC El has been found to be highly immunogenic as it induces 
the majority of the antibody response to intact El. Rice et aL ( 1992) have also observed 
that tryptic digestion of bovine OGDC causes loss of overall OGDC activity due to the 
dissociation of the El and E3 components, although the El ' fragment retains full 
catalytic activity.
■Ï
%
,Figure 4.5 compares the unfolding and reactivation of E l to El assayed in the 
intact complex. From these data it can be seen that the tryptic digestion of El does not 
affect the loss or regain of El activity. Both the undigested and digested El show a 
complete loss of activity after incubation and assaying in 1.2M GdnHCl at which 
concentration 50% of activity can be recovered on dilution of the dénaturant. As in the
84
intact E l, ability to recover activity reduces progressively over the range 0.8-2.2M 
GdnHCl.
4.5 Investigating the effect of calcium on E l and E l of bovine heart OGDC
85
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,To investigate whether the tryptic digestion of El to El affects the calcium 
requirements of the component, calcium was removed from the complex by dialysis 
against 3 x 100 volumes of 20 mM TrisHCl, pH 7.0 containing the calcium chelator 
EGTA at 0.1 mM. This procedure removed the calcium from the solution and no 
changes were observed when dialysis was carried out with 6 x 100 volumes of buffer 
over 6 days, although it is possible that tightly associated calcium ions remained with 
the complex. The dialysed OGDC was then selectively digested with trypsin as 
described in section 4.3. The digestion was found to proceed more slowly than that 
carried out with calcium present and trypsin levels were increased to 0.15% (w/w) to 
avoid incubating the complex at 30°C for longer than was necessary to minimise 
possible structural damage to other constituent enzymes. The results displayed in Figure
4.6 were carried out on intact or digested OGDC at a concentration of 1 mg/ml. In the 
digested complex the El and E3 components have been shown previously to dissociate 
from the complex while the smaller 10 000 Mr N-terminal fragment yielded by the
.tryptic digestion remains tightly bound to the core (Rice et al, 1992). From Figure 4.6 it 
can be seen that there is a distinct difference in Km from 4.4 xlO"^ to IxlO ^M when El 
activity is assayed in the presence and absence of calcium respectively. For E l' the 
change in Km is similarly distinct, from 8 xlO“5 to lxlO~3 M when assayed in the 
presence and absence of calcium respectively.
Figure 4.4 Selective digestion of OGDC E l with trypsin
Bovine OGDC was diluted to a final concentration of 1 mg/ml with 50mM 
potassium phosphate buffer, pH 7.6 containing 0.2 mM ThDP, 3 mM NAD**" and 1 mM 
MgCl2- Digestion of OGDC was initiated at 30°C by adding 0.1% (w/w) trypsin. 
Aliquots (20 //g)were withdrawn at the times indicated below, mixed with an equal 
volume of Laemmli sample buffer and resolved on a 10% (w/v) SDS-polyacrylamide 
gel. Lane M, low Mr standards (10 fig), lanes 1-8, OGDC digested with trypsin for 0, 1, 
3 ,5 ,7 , 10,20 and 40 min, and lane C control OGDC incubated for 40 min in the 
absence of trypsin.
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Figure 4.5 Comparing the deactivation and reactivation of bovine heart OGDC El 
and EX'
Intact or digested OGDC (1 mg/ml) was incubated at 4°C in 50mM potassium 
phosphate, pH 7.6 containing GdnHCl for 15 min before the extent of inhibition (with 
assay mixture containing the same GdnHCl concentration) or reactivation (GdnHCl 
concentration reduced to below 0.03M by dilution) was assayed for El activity as 
outlined in Materials and Methods. Intact El is represented by the symbols Band Qfor 
inhibition and reactivation respectively. El' is represented by the symbols #  and Ofor 
inhibition and reactivation respectively. In each case the changes are expressed relative 
to control sample from which GdnHCl was omitted. Results shown are averages of 3 
readings taken from different preparations differing by no more than plus or minus 5%.
8 8
____
4.6 Comparing unfolding and reactivation of E2 from bovine heart and E. coli
Figure 4.7 compares the unfolding and reactivation of E2 from bovine heart PDC 
and E. coli PDC after incubation for 15 min with increasing concentrations of GdnHCl. 
The activity of the E. coli E2 was measured as described in Materials and Methods. The 
bovine heart PDC E2 data are taken from West etal. (1995) and activity was found to be 
the same when measured by two independent methods. The first is a. 
spectrophotometrical determination comprising a coupled assay employing 
phosphotransacetylase to generate acetyl-CoA from acetyl phosphate and Co A as a 
substrate for the E2-driven acétylation of free dihydrolipoamide to the S-acetyl 
derivative. This was detected in a colorimetric assay as the ferric acetohydroxamate 
complex. The second is the isotopic conversion of [1- acetyl-CoA to the radio 
labelled S-acetyl dihydrolipoamide intermediate which was then extracted into toluene 
as in the method used to measure E2 activity in E. coli PDC. While the data shown in 
Figure 4.7 compare isolated bovine PDC E2 to complex intact E coli PDC E2, it has 
been shown previously that in the bovine heart PDC the E2 has an identical response to 
GdnHCl-induced unfolding and reactivation whether it is within the complex or isolated 
(West, unpublished work). From Figure 4.7 it can be seen that E2 from these two 
sources has a similar response to GdnHCl incubation. In both cases inactivation of E2 is 
complete after incubation and assaying in l.OM GdnHCl. Reactivation of E2 is 1(X)% 
after incubation in I .OM GdnHCl but gradually decreases as the concentration of 
GdnHCl increases with 50% recovery occurring after 3.OM GdnHCl incubation in both 
cases. From the data it would appear that the bovine heart PDC E2 is marginally more 
sensitive to incubation with 3.0-5.0M GdnHCl.
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Figure 4.6A Comparing the effect of calcium ions on the activity of intact E l and 
E l
Calcium was first removed from the complex by dialysing against 3 x 100 
volumes of 20 mM TrisHCl, pH 7.0 containing 0.1 mM EGTA. Digestion was then 
carried out as described in Figure 4.4 while monitoring both whole complex and El 
activity as outlined in Materials and Methods. Whole or digested OGDC (both 1 mg/ml) 
were then assayed for E l activity without calcium present in solution A containing 1 
mM EGTA and with calcium present by adding a 5-fold molar excess of CaCl2 to the 
solution A. The concentration of 2-oxoglutarate was varied as shown in the figure. El 
results are represented by ■ (with calcium)and □ (without calcium). E l’ results are 
represented by #  (with calcium) and O (without calcium). The results shown are 
averages taken from 2 different preparations differing by no more than plus or minus 
7%.
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Figure 4.6B Lineweaver-Burk plot of E l and El' assayed in the presence and 
absence of calcium
These data are those represented in Figure 4.6A and the previous legend reports 
the procedures employed to obtain them. El results are represented by ■ (with calcium) 
and□ (without calcium). E l' results are represented by #  (with calcium)andO (without 
calcium).
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Figure 4.7 Comparing the deactivation and reactivation of bovine heart and E. coli 
PDC E2
E. coli PDC (1 mg/ml) was incubated at 4°C in 50mM potassium phosphate, pH
7.6 containing GdnHCl for 15 min before the extent of inhibition (with assay mixture 
containing the same GdnHCl concentration, A) or reactivation (GdnHCl concentration 
reduced to below 0.03M by dilution, A) of E2 was assayed isotopically via the 
conversion of [1-C acetyl-CoA to the radiolabelled S-acetyl dihydrolipoamide 
intermediate as outlined fully in Materials and Methods. In each case the changes are 
expressed relative to control sample from which GdnHCl was omitted. Results shown 
are averages of 2 readings taken from different preparations. The extent of inhibition (■) 
and reactivation (□) of isolated bovine heart PDC E2 results are taken from West etal. 
(1995).
93
M
4.7 Deactivation and reactivation of the E3 component
Dihydrolipoamide dehydrogenase (E3) is the common component of the three 2- 
oxoacid dehydrogenase complexes oxidising pyruvate, 2-oxoglutarate and the branched- 
chain 2-oxoacids. Investigating the E3 component is particularly interesting because of 
the high degree of sequence homology observed between species for this component. 
Figure 4.8 shows the unfolding and reactivation of bovine heart and E. coli PDC E3. The 
assays have been performed in the presence of the whole complex. From this figure, it 
can be seen that both E3s behave similarly when incubated and assayed in GdnHCl. 
Inactivation proceeds gradually over the range of 0-1.2M GdnHCl with 97% of activity 
lost after incubation and assaying in 1 .OM GdnHCl. Figure 4.8 also shows, however, that 
there is a striking difference in the recovery of activity after GdnHCl incubation of the
E3 from these two sources. For the bovine heart E3, recovery of activity decreases 
progressively when the complex is incubated in 1.4-2.8M GdnHCl, with 50% of activity 
lost after incubation with I 8M GdnHCl. The recovery of E3 activity of E. coli PDC 
decreases progressively after incubation in 3.1-4.5M GdnHCl, with 50% of activity lost 
after incubation with 4.0M GdnHCl.
4.8 Isolation of the E3 component
To investigate the possible stabilising effect of the presence of the rest of the 
complex and to enable CD and fluorescence data to be collected, E3 was isolated from 
bovine heart and E. coli PDC. For the bovine heart complex, isolation was carried out as 
described in Materials and Methods. This method of heat treatment was adapted to 
isolate E3 from E. coli PDC. During purification of the complex it was found that a
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Figure 4.8 Deactivation and reactivation of bovine heart and E. coli PDC E3
Bovine heart OGDC or E. coli PDC (both 1 mg/ml) was incubated at 4°C in 
50mM potassium phosphate, pH 7.6 containing GdnHCl for 15 min before the extent of 
inhibition (with assay mixture containing the same GdnHCl concentration) or 
reactivation (GdnHCl concentration reduced to below 0.03M by dilution) was assayed 
for E3 activity as outlined in Materials and Methods. Inhibition results are represented 
by Band ▲ for bovine heart and E. coli E3 respectively. Reactivation results are 
represented by □ and A for bovine heart and E. coli E3 respectively. In each case, the 
changes are expressed relative to control sample from which GdnHCl was omitted. 
Results shown are averages of 3 readings taken from different preparations differing by 
no more than plus or minus 5%.
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4.9 Comparing the unfolding and reactivation of E3 within the complex to isolated 
E3
after GdnHCl incubation in the range 1.4-2.8M, a concentration at which the E3 assayed
96
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considerable amount (ranging from 28-40%) of E3 activity remained in the supernatant
r-:.
of the final ultracentrifugation step. Figure 4.9 shows heat treatments carried out on this "'I'supernatant at 65-85"C and from this it can be seen that at 65"C the E3 still retains 1(X)% 
of its activity after a 30 min incubation. Increasing the temperature above this gradually 
increased the rate of activity loss of E3. Figure 4.10 shows the SDS PAGE analysis of Isamples taken during the 65"C heat treatment. Using both the E3 activity assays and §
SDS-PAGE analysis, an incubation of 20-30 min at 65"C was chosen to isolate the E3
rcomponent from the supernatant although the treatment varied slightly between 
preparations and was monitored closely each time it was performed.
Figure 4.11 compares the unfolding and reactivation of isolated and complex 
bound bovine heart E3. In both cases it can be seen that when incubated and assayed 
with GdnHCl E3 activity is progressively lost between 0 and 1.2M GdnHCl with 97% of 
activity lost after incubation in 1.0 M GdnHCl. The recovery of activity after GdnHCl 
incubation is also very similar in both the isolated and complex intact data. Full activity 
is recovered on dilution after incubation in 1.4M GdnHCl. As the dénaturant 
concentration is increased to 2.8M GdnHCl recovery progressively decreases to 0% in
both cases. Figure 4.12 compares the unfolding and reactivation of E. coli E3 in the
î;i.presence of the rest of the PDC complex to isolated E3. From this figure it is clear that 
there is a striking difference in the recovery of E3 activity on dilution after GdnHCl 
incubation between the two situations. When E3 recovery is assayed in the presence of 
the complex, recovery is 100% when incubation is at 3.0M GdnHCl and decreases to 0% 
after incubation in 4.5M GdnHCl. Isolated E. coli PDC E3 loses the ability to recover
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Figure 4.9 Monitoring the stability of the E. coli PDC E3 component during heat 
treatment
Bacterial PDC (2 mg/ml) was pre-incubated in 50mM potassium phosphate 
buffer, pH 7.6, containing 2.0M NaCl for 15 min on ice before heat treatment began. 
After the heat treatment at the stated temperature for the stated length of time, the 
sample was removed from the water bath and spun for 10 min at 15000g. The 
supernatant was then assayed for E3 activity as described in Materials and Methods. 
Heat treatments were carried out at 65°C (O), 70°C (A), 75°C (□), 80°C (#) and 
85°C(«).
97
Figure 4.10 SDS-PAGE analysis of samples taken during the 65“C heat treatment 
o ïE .co li PDCE3
The supernatant from the final high speed centrifugation step of the E. coli PDC 
preparation was incubated in 50mM potassium phosphate buffer, pH 7.6, containing 
2.0M NaCl for 15 min on ice before the 65°C heat treatment began. At the times stated 
10/^g aliquots were withdrawn and mixed with an equal volume of Laemmli sample 
buffer and resolved on a 10% (w/v) SDS-polyacrylamide gel. Both lanes labelled M are 
low Mr standards (10/rg). Lanes 1-5 are supernatant containing E3 treated for 0, 5, 10, 
20 and 30 min.
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Figure 4.11 Comparing the deactivation and reactivation of isolated and complex 
bound bovine heart E3.
Bovine PDC (1 mg/ml) or purified bovine E3 (0.1 mg/ml) was incubated al 4°C 
in 50mM potassium phosphate, pH 7.6 containing GdnHCl for 15 min before the extent 
of inhibition (with assay mixture containing the same GdnHCl concentration, complex 
and purified E3 are represented by Hand #  respectively) or reactivation (GdnHCl 
concentration reduced to below 0.03M by dilution, complex and purified E3 are 
represented by □ and O respectively) was assayed for E3 activity as outlined in 
Materials and Methods. In each case the changes are expressed relative to control 
sample from which GdnHCl was omitted. Results shown are averages of two readings 
taken from different preparations differing by no more than plus or minus 5%.
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Figure 4.12 Comparing the deactivation and reactivation of isolated and complex 
bound E. coli E3.
E. coli PDC (1 mg/ml) or purified E. coli E3 (0.1 mg/ml) was incubated at 4“C 
in 50mM potassium phosphate, pH 7.6 containing GdnHCl for 15 min before the extent 
of inhibition (with assay mixture containing the same GdnHCl concentration) or 
reactivation (GdnHCl concentration reduced to below 0.03M by dilution) was assayed 
for E3 activity as outlined in Materials and Methods. Inhibition results are represented 
by #  and A for complex and purified E3 respectively. Reactivation results are 
represented by O and A for complex and purified E3 respectively. In each case the 
changes are expressed relative to control sample from which GdnHCl was omitted. 
Results shown are averages of 3 readings taken from different preparations differing by 
no more than plus or minus 5%.
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with the complex still recovers 100% of activity on dilution. The presence of the E2
component has also caused a minor decrease in susceptibility to GdnHCl unfolding of
.E3. From Figure 4.12, it can be seen that 50% of E3 activity is lost after incubation and
assaying in 0.2 and 0.3M GdnHCl for isolated and complex associated E3 respectively.
ïî
4.10 Comparing the unfolding and reactivation of E3 isolated from 3 different 
sources
Figure 4.13 shows the results of GdnHCl induced unfolding and subsequent 
reactivation of E3 isolated from bovine heart, yeast and E. coli. E3 from these 3 sources 
can be seen to behave in a similar way when incubated and assayed in GdnHCl, (A).
Activity is lost over the range 0-1.2M GdnHCl with 50% of activity lost at around 0.2M 
GdnHCl. The ability to regain activity after dilution from GdnHCl incubation is also lost 
over the same range for the different E3s, (B), this range being 1.0-2.2M GdnHCl, with 
50% of activity regained at 1.8, 1.7 and 1.5M GdnHCl for E. coli, bovine heart and 
yeast E3 respectively.
.'I
4.11 Monitoring changes in fluorescence and CD properties on GdnHCl induced 
unfolding of E3 from 3 different sources
1-
The unfolding of the isolated E3 components by GdnHCl was also monitored by 
changes in protein fluorescence and far-UV CD. The results are showing Figures 4.14 
and 4.15, in terms of the changes in these parameters relative to the total changes
occurring between 0 and 6M GdnHCl although in both cases very little change at all was
.detected between 4 and 6M GdnHCl. In each case the fluorescence emission maximum 
and the size of the ellipticity at 225nm indicated that E3 was completely unfolded in 6M 
GdnHCl. For the 3 E3s the changes in CD (reflecting the loss of secondary structure)
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Figure 4.13 Deactivation (A) and reactivation (B) of purified E3 from yeast, E. coli 
and bovine sources.
E. coli E3, ▲, (0.1 mg/ml), bovine E3, H, (0.1 mg/ml) or yeast E3, #,(0.2 
mg/ml) was incubated at 4°C in 50mM potassium phosphate, pH 7.6 containing GdnHCl 
for 15 min before the extent of inhibition (shown in A where assay mixture contained 
the same GdnHCl concentration as incubation) or reactivation (shown in B where 
GdnHCl concentration has been reduced to below 0.03M by dilution) was assayed for 
E3 activity as outlined in Materials and Methods. In each case the changes are expressed 
relative to control sample from which GdnHCl was omitted.
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Figure 4.14 Unfolding E3 from bovine heart, E. coli and yeast PDC as monitored 
by changes in circular dichroism
E. coli E3, A, (0.1 mg/ml), bovine E3, #  (0.1 mg/ml) or yeast E3, # , (0.17 
mg/ml) was incubated at 4°C in 50mM potassium phosphate, pH 7,6 containing GdnHCl 
for 15 min prior to the changes in ellipticity at 225nm being recorded as outlined in the 
Materials and Methods section.
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Figure 4.15 Unfolding E3 from bovine heart, E. coli and yeast PDC as monitored 
by fluorescence properties
E3 was incubated at 20°C in 50mM potassium phosphate, pH 7.6 containing 
GdnHCl for 15 min prior to measurement. In each case the changes are expressed 
relative to the total change observed between 0 and 6M GdnHCl. The excitation 
wavelength in each case was 290 nm and the emission wavelength was 350 nm. The 
concentrations of bovine heart (■), E. coli (A), and yeast ( • )  E3 were each 80/fg/ml.
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and fluorescence (reflecting the loss of tertiary structure as reported by the exposure of 
internally located tryptophan residues to the external solvent) occur over comparable 
ranges of GdnHCl incubation concentration (1-3 M). From Figure 4.15 it can be seen 
that the yeast E3 has increased stability to tertiary structural changes measured in this 
way with 50% of the total change occurring at 2.6M compared to L8M for both E. coli
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and bovine heart E3.
4.12 Discussion
The results described in this chapter shed light on the properties of the 
component enzymes of PDC and OGDC from bovine heart, E. coli and S. cerevisiae.
Comparing the data for individual component assays to those for the whole complex 
shown in Chapter 3 (Figures 3.2 and 3.4), it is clear that loss of complex activity on 
GdnHCl incubation occurs at lower GdnHCl concentrations than the loss of activity of 
the most sensitive component enzyme. The El component catalyses the only irreversible 
reaction in the multistep activity of the 2-oxoacid dehydrogenases, the initial
'decarboxylation of the 2-oxoacid, which is the rate limiting step of the overall reaction 
(Walsh et aL, 1976). While a common ThDP binding motif has been identified on all 
known El components (Hawkins etaL, 1989), sequences available for El of PDC and 
OGDC show little overall homology even when extracted from the same source 
(Darlison etaL, 1984). The quaternary structure of the El component is another 
difference between sources. The El components of bacterial and mammalian OGDC and 
Gram negative bacterial PDC are homodimers (Koike and Koike, 1976). In contrast, the 
E l component from eukaryotic and Gram positive bacterial PDC is composed of two 
non-identical subunits , a  and p, which form a  2^2 tetramers (Reed et ai, 1985).
Despite this the 3 El components investigated in this chapter show very similar 
unfolding and reactivation curves shown in Figures 4.1,4.2 and 4.3. To investigate the
I
.  .possible contribution of the complex core to the stability of the El component, the 
protease trypsin was used to cleave bovine heart OGDC El into 2 stable fragments. The
smaller Mf 10 000 fragment has been found to have significant similarities with 
equivalent lipoyl domain regions of protein X and E2 sequences of bovine heart PDC. 
The larger Mr 100 000 fragment, ET, is released from the core on cleavage, as is the E3 
component (Rice etaL, 1992). An observation worthy of further investigation is noted 
from Figure 4.4. The gradual appearance of two stable bands during the tryptic digestion 
of approx. 38 000 Da and 31 000 Da occurs concurrently with the disappearance of the 
ET fragment. This limited digestion of E l' apparently does not affect the El activity as 
this was routinely between 90 and 95% after a 10 min tryptic digestion, and at this time 
on Figure 4.4 it can be seen that the intensity of the E l' band has reduced to around half 
that of the 3 min sample. Figure 4.5 shows that E l' (or the E l' fragments) behaves 
identically to the undigested El component when unfolding and reactivation are assayed 
after GdnHCl incubation. The smaller product of the trypsin cleavage of bovine heart
OGDC has previously been found to be highly immunogenic and as yet the reason for 
this characteristic is uncertain. Figures 4.6A and 4.6B show data investigating whether 
this area of the protein may be involved in calcium control of the complex. Figure 4.6B 
shows that the Krn for El rises from 4.4 x 10“^  to 1 x 10"^M when calcium is removed.
ÏFor E l' a similar rise of 8 x 10"  ^to 1 x 10“^ M is observed. These values indicate that 
calcium plays an important role in complex regulation as physiological levels of calcium 
are generally in the range 10-100/iM. However, it is unlikely, given these results, that 
the small fragment cleaved from El during trypsin digestion is involved in this 
regulation.
It has previously been shown that for bovine heart PDC, E2 loses the ability to
regain activity at substantially higher initial GdnHCl concentrations (2-4M) than the El
.and E3 components (West etaL, 1995). Figure 4.7 compares these data with similar 
measurements collected for E, coli E2 and here it can be seen that the core component is
'I
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found to recover activity after GdnHCl incubations over the range 2-5M with 50% of 
activity being recovered after a 3.CM GdnHCl incubation. As the E2 components form 
the structural core of the complexes, it is possible that this ability to regain activity from 
higher GdnHCl concentrations in vitro, may reflect a physiological role of the E2 
component, that of providing a framework which helps the other components to attain 
their native structure. To investigate whether there is a difference between reactivation 
results from isolated and complex associated components, purification of E3 from 
bovine heart and E. coli PDC were carried out. Figure 4.11 confirms that for bovine 
heart E3 there is no significant difference in reactivation between the isolated and 
complex associated sates. This is to be expected as it has previously been shown that the 
E3 component is completely dissociated from the bovine heart PDC complex after 
incubation in O.IM GdnHCl (West etaL, 1995). The method of purification of the E. 
coli PDC complex, in particular the Resource Q column step, indicates that the E3 
component in this complex is more tightly bound to the central core. Figure 4.12 shows 
the striking difference found between the isolated and complex associated forms of E3 in 
the E. coli PDC complex. Recently it has been shown that the binding to E2 occurs 
across the E3 dimer interface (Mande et al, 1996b). The structure of E3 from B. 
stearothermophilus present within the complex shows very little deviation from that of 
uncomplexed E3. Similarly, the E3 binding domain on E2 is almost structurally identical 
when either free or complexed with E3 (Mande et ai, 1996b). As both components 
appear to undergo little overall conformational change upon complex formation, 
recognition is thought to occur via a lock and key' rather than an 'induced fit' 
mechanism. From the data presented here it is clear that E3 is stabilised by association 
with the E2 core. This stabilisation is probably almost entirely due to electrostatic 
interactions between the binding domain and residues from the interface domain of both 
E3 monomers.
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From Figures 4.14 and 4.15 it can be seen that for E3, enzyme activity is lost at 
GdnHCl concentrations where no secondary or tertiary structural changes have occurred 
as monitored by far-UV CD and protein fluorescence respectively. This is consistent 
with the proposal that the precise architecture of the active site of an enzyme is much 
more easily perturbed than the overall structure (Tsou, 1986). The ability to regain 
activity on subsequent dilution of GdnHCl to below 0.03M has previously been shown, 
for bovine heart PDC, to correlate with the integrity of the secondary structure (West et 
al, 1995). Comparing Figures 4.13 and 4.14 it is evident that this is also the case for the 
three E3s investigated here. On incubation and assaying E3 in GdnHCl, 95% of activity 
is lost over the range Ü-0.8M. At these low concentrations of dénaturant no secondary 
structural changes are detected using circular dichroism. Recovery of activity on dilution 
decreases over the range 1-2M GdnHCl and Figure 4.14 shows that 47%, 52% and 60% 
of the secondary structure has been lost at 2.0M GdnHCl by yeast, E. coli and bovine E3 
respectively. Dilution after incubation above 2.2M GdnHCl does not result in any regain 
of activity suggesting that under these conditions E3 cannot refold after loosing around 
70% of its native secondary structure.
This correlation between regain of activity and loss of secondary structure has 
been reported previously for a number of other imported mitochondrial enzymes such as 
glutamate dehydrogenase (West and Price, 1988), fumarase (Kelly and Price, 1991) and 
citrate synthase (West et al, 1990). This is in contrast to the situation with some 
cytoplasmic enzymes, which appear to refold and reassemble with at least moderate 
efficiency after dénaturation (Jaenicke, 1987). Indeed in some cases comparing the 
mitochondrial and cytosolic isoforms of the same enzyme has revealed clear differences 
in recovery of activity after GdnHCl incubation. West and Price (1990) have shown that 
for aspartate aminotransferase while the cytosolic isoform can recover activity on 
dilution from incubation in 6M GdnHCl, the mitochondrial isoform looses the ability to 
regain activity on dilution over the incubation range 1.0-2.0M GdnHCl. Examples such
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as these led to the suggestion that the reason why many mitochondrial enzymes are 
significantly less stable than comparable cytosolic enzymes was associated with the 
unfolded state which is required for translocation of protein across the mitochondrial and 
other membranes. The requirement of chaperone proteins in the folding and assembly 
process of these imported mitochondrial proteins has also been suggested to help to 
explain their inability to refold from a completely unfolded state under the conditions 
used in vitro. More recently though, a number of mitochondrial proteins have been 
shown to reassemble after dénaturation, including bovine heart PDC E2 (De Marcucci et 
aL, 1995), suggesting that the ability to refold proteins in vitro may have less to do with 
the proteins cellular location than was once thought.
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CHAPTERS
INVESTIGATION OF THE E3 REFOLDING ENVIRONMENT
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5.1 Introduction
The assembly of complexes as large as the 2-oxoacid dehydrogenases poses 
interesting questions as to how this process occurs in vivo. As all the integral 
polypeptides of the mammalian complexes are nuclear-encoded and are synthesised as 
larger-Mf precursors on cytoplasmic ribosomes (Hunter and Lindsay 1986; De Marcucci 
et aL, 1988; Jackman et al., 1990; Clarkson and Lindsay 1991), it is clear that import 
across both mitochondrial membranes and proteolytic cleavage of the extended 
presequences must occur before assembly into mature complexes. The precursor form of 
E2 from OGDC has been found not to be recognised by antibodies against native E2, 
suggesting that the precursor is present in the cytoplasm in an unfolded state with no 
conformational similarity to the mature E2 (Hunter and Lindsay, 1986). It has become 
clear that several additional factors are involved in maintaining this unfolded state in the 
cytoplasm, presentation and translocation of the mitochondrial membranes and attaining 
functional maturity. These factors include mitochondrial receptors, proteases and 
chaperone proteins. In the cytoplasm, chaperone proteins are responsible for newly 
synthesised subunits remaining in a translocation-competent state for delivery to the 
mitochondrial surface. The mitochondrial chaperone protein hsp70 appears to have a 
dual role in facilitating the movement of the translocation intermediate through 
mitochondrial contact sites into the matrix and then presenting this intermediate to the 
hsp60 system which is implicated in the functional maturation of the intact complex 
(Gething and Sambrook, 1992). Stuart et al . (1994) have recently shown that in 
Saccharomyces cerevisae folding of the mitochondrial precursors in vivo is mediated by 
sequential interactions with a series of chaperones which are homologues of the E. coli 
dnaK, dnaJ, grpE, groEL and groES proteins. Although chaperone proteins are believed 
to be involved in assisting the folding of the individual components of the 2-oxoacid 
dehydrogenase complexes, the association of the folded subunits is thought to be an
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entirely spontaneous process, as is demonstrated by the reversibility of the loss of 
complex activity after dilution from low concentration dénaturant incubations (Figures
3.2 and 3.4).
To investigate the potential interaction between chaperone proteins and the 2- 
oxoacid dehydrogenase complexes, this chapter is involved in examining the effect of 
groEL and groES on the refolding of the purified E3 component from 3 different 
sources. Also in this chapter, the requirement of the presence of non-covalently bound 
E3 cofactor, FAD, for optimal renaturation is investigated. The effect of its 
concentration and time of addition to the refolding protein are reported. In addition, the 
effects on the refolding yield of protein concentration and the inclusion of a reducing 
agent in the refolding buffer have been studied.
5.2 Investigating the effect of the FAD cofactor on the E. coU E3 refolding yield
Pilot studies revealed at an early stage that no significant recovery of bacterial E3 
activity was obtained without the addition of exogenous FAD. Figures 5.1 and 5.2 
illustrate the effects of FAD at various concentrations on the E. coli E3 refolding 
process. Figure 5.1 shows that there is an increase in the regain of activity on inclusion 
of a twofold molar excess of FAD to the refolding buffer, in addition to the endogenous 
FAD present. This regain appears to be maximal at a 5 molar excess of FAD as 
increasing the concentration further did not produce a significantly higher yield of E3 
activity. Figure 5.2 shows a time course of E. coli E3 recovery after GdnHCl-induced 
unfolding. It can be seen that the activity recovers steadily between 0 and 120 min and a 
maximum of 24% of activity is recovered compared to a non-denatured control 
incubated at the same temperature. No recovery of activity was detected with 
endogenous FAD alone under these conditions.
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Figure 5.1 Investigating the effect of FAD concentration on the refolding of E. coli 
E3
E. coli E3 was unfolded by incubating for 15 min at 4°C in 50mM potassium 
phosphate, pH 7.6 containing 4M GdnHCl. Refolding was initiated by 60-fold dilution 
into 50mM potassium phosphate pH 7.6, containing the stated added molar excess of 
FAD. E3, final concentration after dilution lO/tg/ml, was assayed as described in 
Materials and Methods after 180 min of incubation at 25°C after dilution.
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Figure 5.2 Comparing reactivation of E. coli E3 in the presence and absence of 
FAD
E, coli E3 was unfolded by incubating for 15 min at 4°C in 50mM potassium 
phosphate, pH 7.6 containing 4M GdnHCl. Refolding was initiated by 60-fold dilution 
into 50mM potassium phosphate pH 7.6 with (■), and without (gD, a 5 x molar excess of 
FAD. E3, final concentration after dilution lOjug/ml, was assayed as described in 
Materials and Methods.
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5.4 Chaperone involvement in the E3 refolding process
Table 5.1 displays the results of various refolding experiments investigating the 
effect of a number of agents on the yield of E3 activity after GdnHCl-induced unfolding. 
Attempts to refold yeast and bovine E3 under this selection of conditions have proved to
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5.3 Investigating the effect of GdnHCl concentration on the ATPase activity of 
groEL
■
Before investigating the effect of GroEL on the refolding of E3, Figure 5.3 
shows the results of an experiment to determine what effect if any the residual GdnHCl 
concentration, after dilution, would have on the ATPase activity of GroEL. ATPase 
activity readings were taken for GroEL incubated in a range of GdnHCl concentrations 
between 0-0.7M. From Figure 5.3 it can be seen that there is a steady decrease in the 
ATPase activity of GroEL as the concentration of GdnHCl incubation increases in this 
range with no remaining activity detectable at 0.7M. The final concentration of GdnHCl 
after dilution in the E3 refolding experiments is 0.07M at which, it can be seen from 
Figure 5.3, 94% of GroEL ATPase activity remains. From this determination, it was 
concluded that the residual GdnHCl concentration would not significantly interfere with 
potential E3 refolding by the chaperone protein.
â.
be unsuccessful. E. coli E3 refolding, however, can be achieved routinely to varying
degrees from a completely unfolded state. Surprisingly, ESA was able to promote 
similar limited E3 refolding at the same protein concentration as GroEL, GroES and 
ATP. This effect is probably due to the external hydrophobic surface of BSA interacting 
with individual E3 molecules, effectively reducing the chances of aggregation occurring 
between folding E3 monomers. FAD, in conjunction with various combinations of the 
other agents, can be seen to be an important factor in E3 refolding, increasing the yield
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Figure 5.3 Changes in the ATPase activity of groEL in the presence of GdnHCl
GroEL (0.7 mg/m!) was incubated in 50 mM triethanolamine containing 10 mM 
magnesium acetate and the corresponding GdnHCl concentration (pH 8.0) for 15 min at 
20‘'C before the ATPase assays were carried out as described in Materials and Methods. 
The kcat values calculated are expressed here as a percentage of the value for groEL 
incubated under the same conditions with no GdnHCl. Results shown are the averages of 
two sets of data taken from different groEL preparations.
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Table 5.1 Investigation of the refolding of E, coli, yeast and bovine E3
E3 was unfolded by incubating for 15 min at 4°C in 50mM potassium phosphate, 
pH 7.6 containing 4M GdnHCl. Refolding was initiated by 60-fold dilution into 50mM 
potassium phosphate pH 7.6 containing the stated additions. The final concentration of 
E3 after dilution was 15/<g/ml in each case. A 4-fold molar excess of GroEL was present 
where stated so that four 14-mer GroEL molecules were present for each refolding E3 
subunit. Similarly a 4-fold molar excess of GroES 7-mers were present where stated. 
FAD and FMN were present at 5-fold molar excess compared to E3 monomers. ATP 
was present at 3//M, a 5 fold molar excess compared to GroEL 14-mers. BSA was 
present at 1.0 mg/ml, a concentration identical to that of the GroEL. DTT was present at 
1 mM. After 180 min refolding at room temperature E3 was assayed as described in 
Materials and Methods and the results displayed here are relative to a non-denatured 
control sample incubated in the same way. Figures shown are averages of 3 runs for 
each set of refolding conditions for E. coli using E3 from different preparations and 
results were all within +/- 10% of the stated values.
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Additions to refolding buffer Reactivation at 180 min (%)
E, coli Yeast Bovine
None 0,0 0.0 0.0
GroEL, GroES, ATP 15.2 0.0 0.0
BSA 14.1 0.0 0.0
FAD, GroEL, GroES, ATP 61.0 0.0 0.0
FAD, BSA 41.5 0.0 0.0
FAD, GroEL 44.2 - -
FAD, GroEL, ATP 51.2 0.0 0.0
DTT 15.5 - -
BSA, FAD, DTT 62.0 - -
FMN 0.0 0.0 0.0
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from 15.2 to 61% when included in the GroEL, GroES and ATP experiment. These 
results support the idea of FAD creating a folding nucléation site at the N-terminal FAD 
binding site on E3. FMN, however, was unable to replace FAD in promoting the E3 
refolding process.
5.6 Effect of varying the concentration of E3 on the refolding yield
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5.5 Effect of time of FAD addition to the refolding E3
■.■1
As inclusion of FAD in the refolding buffer has been shown to have a major
influence on the refolding yield of E. coli E3, the time of its addition after dilution has
been investigated. Figure 5.4 shows the results of this experiment where FAD (5-fold
molar excess) has been added at between 0 and 75 min after dilution from 4M GdnHCl.
From this figure, it is apparent that the recovery at 180 min, when FAD is added at 10 or 
. .20 min is at a similar level to the 0 min value, 24%. By 30 and 40 min the recovery has 
fallen to 16 and 7% respectively at 180 min. No recovery is detected when the FAD is
added to the refolded mixture at 75 min and the activity monitored for 240 min.
Figure 5.5 shows the results of E3 refolding experiments where the concentration 
of E3 has been varied between 0.5 and 30 /rg/ml. In each case FAD was included in the 
refolding buffer in a 5-fold molar excess with respect to E3 monomers. Figure 5.5 shows 
clearly that for E3 the concentration of the refolding protein influences the yield of 
activity regain after 180 min. At the E3 concentrations investigated the regain of activity 
varied between 24 and 36% of a non-denatured sample incubated in otherwise the same 
conditions. The optimum concentration from these data, with 36% reactivation, occurred 
with an E3 concentration of 20pg/ml.
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Figure 5.4 Investigating the effect of the time of FAD addition on the refolding of E.
coU E3
E, coli E3 was unfolded by incubating for 15 min at 4“C in 50mM potassium 
phosphate, pH 7.6 containing 4M GdnHCl. Refolding was initiated by 60-fold dilution 
into 50mM potassium phosphate pH 7.6 and E3 assayed as described in Materials and 
Methods at the times shown above after the addition of 5 times molar excess of FAD in 
each case. The final concentration of E3 after dilution was 5/<g/ml. FAD was added 0 
(#), 10 (#), 20 (A), 30 (□), 40 (A) and 75 (O) min after dilution out of GdnHCl.
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Figure 5.5 Investigating the effect of E3 concentration on reactivation yield
E. coli E3 (2 mg/ml) was unfolded by incubating for 15 min at 4°C in 50mM 
potassium phosphate, pH 7.6 containing 4M GdnHCl. Refolding was initiated by the 
appropriate dilution (minimum 60-fold) to give the stated E3 concentrations in buffer 
containing a 5 fold molar excess of FAD in each case. E3 activity was assayed at 180 
min as described in Materials and Methods. The results shown are an average of 2 sets 
of data taken from different E3 preparations.
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5.7 Investigating FAD release during E. coli PDC E3 unfolding
To investigate at what point during GdnHCl-induced unfolding FAD is released 
from E3, incubation was first carried out in a range of GdnHCl concentrations for 15 
min at 4“C. Centrifugation using Centricon tubes with a 10 000 Mr cut-off enabled the 
released FAD in each of these incubations to be separated from that still associated with 
E3. Fluorescence readings taken on the run through from the Centricon spins are shown 
in Figure 5.6. From the trace it can be seen that there is a rapid increase in fluorescence 
in the samples obtained from the 1.5-2.4M GdnHCl incubations, indicating that it is in 
this range in which FAD is released from E3 unfolded under these conditions. Figure 5.7 
shows the results of far-uv CD scans on E3 incubated with 0-3M GdnHCl to investigate 
FAD release in this way. From these results it is evident that there is little change 
between the OM and l.OM GdnHCl scans, indicating that no FAD has been released 
after incubation in l.OM GdnHCl. Between l.OM and 3.0M GdnHCl both the amplitude 
and the wavelength of the peak are observed to change with the largest change in 
amplitude occurring between 2.5M and 2.6M GdnHCl incubations. The peak 
wavelength shifts from 370 nm to 380 nm for OM and 3.0M GdnHCl incubations, 
respectively.
5.8 Structural changes on dilution from 4M GdnHCl incubation
Figure 5.8 shows the fluorescence scans of E. coli E3 after three different 
treatments. Trace A shows the native protein, trace B the denatured protein in 6.0 M 
GdnHCl and trace C 10 min after dilution out of 6.0 M GdnHCl. From this figure it is 
clear that the fluorescence scans of denatured and native E3 are distinct. The denatured
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Figure 5.6 Fluorescence studies to investigate the GdnHCl concentration at which 
FAD is released from E3
E3 (1 mg/ml) purified from E. coli was incubated for 15 min at 4°C at the 
appropriate GdnHCl concentration. These solutions were then spun for 30 min at lOK 
using Centricon tubes with a 10 000 Mr cut-off, allowing free FAD to be separated from 
FAD remaining bound to E3. Fluorescence readings were then taken of this run-through, 
exciting at 450 nm and measuring emission at 535 nm, with the excitation time being 
limited to 1 sec to reduce the occurrence of photobleaching. Results are expressed as a 
percentage of the changes that occurred between 0 and 4M GdnHCl.
123
Figure 5.7 CD scans investigating the dissociation of the flavin group firom E. coU 
E3
E3 (0.75 mg/ml) purified from E. coli PDC was incubated for 15 min at 4°C at 
the appropriate GdnHCl concentration. Scans were then taken between 310 nm and 500 
nm with a 0.5 cm pathlength.
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protein shows a peak at 352 nm of 74 arbitrary units, while the native protein shows a 
peak at 337 nm of 87 arbitrary units. The denatured sample diluted out of GdnHCl 
shows an intermediate peak at 341 nm with an amplitude of 78 arbitrary units, 
suggesting that while the protein has not reached its native state, some folding, or 
possibly aggregation, has occurred. To follow the rate of this structural change, Figure
5.9 shows a time-drive experiment where the intensity of fluorescence at 337 nm is 
monitored in three E3 samples. Trace A shows native E3, trace B denatured E3 in 6.0 M 
GdnHCl and trace C denatured E3 diluted out of GdnHCl at time -5 sec. The figure 
shows that the majority of the change occurs while the dilution and mixing of the sample 
is taking place (between -5 and 0 sec), although during the first 60 sec a continued 
increase in fluorescence intensity occurs. After this time no further change is detected up 
to 90 min. Figure 5.9 illustrates the rapidity of the folding events which are occurring 
upon dilution of the denatured E3.
Light scattering is a useful tool in detecting changes in particle size. 
Oligomerisation or aggregation can be followed by monitoring increases in the light 
scattered by a given sample over time. Emission readings are detected at the same 
wavelength, here 350 nm, but perpendicular to the excitation beam. Table 5.2 shows 
light scattering results for E. coli E3 denatured at 4°C for 15 min in 4M GdnHCl. From 
these data, it can be seen that there is a distinct difference between the native and 
denatured readings. Over the 2 h of monitoring the denatured E3, no significant light 
scattering change was detected indicating that aggregation did not occur.
1 2 6
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Figure 5.8 Fluorescence scans of E. coli E3
Trace A shows native E. coli E3. Trace B shows denatured E. coli E3, unfolded 
by incubating for 15 min at 4°C in 50mM potassium phosphate, pH 7.6 containing 6M 
GdnHCl. Trace C shows E, coli E3, unfolded in GdnHCl in the same way as trace B, 
then refolding was initiated by a 60-fold dilution into the same buffer without GdnHCl. 
Trace C has been taken 10 min after dilution from GdnHCl. The final concentration of 
E3 in each case was 15 /^g/ml. The excitation wavelength was 290 nm and the samples 
were scanned between 310 and 400 nm. The slit widths during this experiment were set 
at 10 nm.
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Figure 5.9 Fluorescence time-drive following the structural changes on dilution of 
E. coli E3 from 6 M GdnHCl
Trace A shows native E. coli E3. Trace B shows denatured E. coli E3, unfolded 
by incubating for 15 min at 4“C in 50mM potassium phosphate, pH 7.6, containing 6M 
GdnHCl. Trace C shows E3 denatured in the same way, then diluted into the same 
buffer without GdnHCl at time -5 sec. The final concentration for each trace was 15 
//g/ml. The excitation wavelength was 290 nm and readings were taken of each sample 
at 337 nm at 1 sec intervals for 5 min. The slit widths during this experiment were set at 
10 nm.
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Time (min) 350 nm emission 
(arbitrary units)
0 202
1 195
2 193
5 191
10 184
45 186
90 191
105 190
120 190
Table 5.2 Light scattering data from E, coli E3 after GdnHCl incubation
E. coli E3 was unfolded by incubating for 15 min at 4°C in 50mM potassium 
phosphate, pH 7.6 containing 4M GdnHCl. Dilution by 60-fold was carried out at 0 min 
to give 80 /fg/ml E3. Light scattering readings were taken at the times stated with the 
excitation and emission wavelengths at 350 nm and both slit widths at 2.5 nm. Native E3 
under the same conditions gave a reading of 284 units.
131
■'A
.s
sH-
■-I
5.9 Discussion
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The E3 component is a member of the pyridine nucleotide disulphide 
oxidoreductase family, a group of homodimeric FAD-dependent enzymes with 
considerable versatility. Crystal structures determined for E3 from Azotohacter 
vinelandii (Schierbeek a/., 1989; Mattevi etaL, 1991), Pseudomonas putida and 
Pseudomonas fluorescens (Mattevi etaL, 1992) reveal the peculiar arrangement of the 
E3 dimer, which has a characteristic butterfly-like shape. The structure of E3 comprises 
four distinct domains: an FAD binding domain, an NAD binding domain, a central 
domain and an interface domain. The FAD and NAD binding domains have similar
■ :
topologies, suggesting that they may have evolved from the duplication of a common 
ancestor. The catalytic centre has been found to be located at the interface between the 
two chains, with one molecule of FAD bound to each subunit in an extended 
conformation. Figures 5.1 and 5.2 show the effect of additional FAD in the refolding 
buffer on the regain of E3 activity.
The requirement of additional FAD for any detectable regain of activity for E. 
coli PDC K  refolding from a completely unfolded state under these conditions is very
i.
interesting. One explanation of this finding is that the binding of FAD is stabilising
segments of secondary and tertiary structure around the FAD binding site, thus enabling 
other areas away from this site to proceed along the folding pathway. The fluorescence 
scans shown in Figure 5.8, however, show that some folding is taking place in the 
absence of additional FAD. The light scattering data in Table 5.2 suggest that this 
fluorescence quenching is not caused by E3 aggregation although even after 90 min the 
native state has not been reached and from Figure 4.12 it can be seen that the ability to 
regain activity is lost after incubation and dilution from much lower GdnHCl 
concentrations. The effect of additional FAD on the refolding of yeast and bovine E3 has 
also been investigated. In Table 5.2, it is reported that both with and without additional I
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FAD no activity is recovered after 180 min with either bovine or yeast E3, Figures 5.6 
and 5.7 show experiments designed to determine at what GdnHCl concentration the 
FAD is released from E3 using visible and near-uv adsorption spectra and fluorescence 
data. CD spectra of flavoproteins in the visible and near ultraviolet flavin light- 
absorbing region are very characteristic and have previously shown a good correlation 
between the type of CD spectrum observed and the particular function of that 
flavoprotein (Edmondson and Tollin, 1971 ; D'Anna and Tollin, 1972; Van Berkel and 
Millier, 1989). From Figure 5.7, it is observed that under the conditions used the FAD 
appears to be released when incubated in 2.0-2.6M GdnHCl. This correlates well with 
the steepest change in the fluorescence intensity measurements shown in Figure 5.6 
which occurs over the range 1.5-2.5M GdnHCl.
The E. coli chaperone protein GroEL and its mitochondrial and plastid 
homologues have been implicated in playing central roles in the folding and/or assemblv 
of a variety of different polypeptides (Martin et ui, 1991 ; Fisher, 1992; Zheng et al., 
1993; Wynn et ai, 1994). The exact mechanism of chaperon in mediated protein folding 
still remains to be fully elucidated. GroEL, however, possesses a weak ATPase activity 
(kcat ^ O.l sec”  ^ per GroEL subunit) and it has been demonstrated that ATP hydrolysis 
is involved in the folding and/or release of polypeptide chains from the GroEl. protein, 
usually in conjunction with its co-chaperonin GroES. Figure 5.3 shows that the low level 
of GdnHCl which is present after dilution out of the 4.0M incubation (maximum 0.07MI 
has only a very minor effect on ATPase activity reducing the value to 94% of the native 
100% value. This effect has not been taken into consideration when calculating the 
chaperone-assisted refolding yields shown in Table 5.1. From Table 5.1 it is observed 
that the addition of groEL, groES and ATP to the refolding buffer gives a refolding yield 
of 15.2% for the E. coli E3. To investigate if this effect was specifically mediated by the 
added chaperone proteins, or due to the increased protein concentration in the refolding 
buffer, regain of activity was also measured with BSA in the refolding buffer to give the
«
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same protein concentration without the potential chaperone action. The inclusion of 
BSA gave a 14.1% regain of activity, suggesting that the increased protein 
concentration, rather than the chaperone activity of groEL and groES, was responsible 
for the activity regained under these refolding conditions. However, a difference is 
observed when comparing the chaperone and BSA refolding buffers when FAD is 
included. Table 5,1 shows that when FAD is included the refolding yields are 61.0% and 
41.5% for the chaperone and BSA refolding buffers respectively. It appears that under 
these refolding conditions GroEL and GroES are causing the regain of more activity 
than can be explained by the effect of increased protein concentration in the refolding 
buffer, suggesting chaperoning was taking place under these conditions. From these data 
the significance of groES in the E3 refolding process is difficult to identify. Table 5.1 
also shows that FMN does not induce refolding unlike FAD. This implies that the entire
IJ
I
FAD cofactor, not only the isoalloxazine and ribitol portions, have a role to play in 
stabilising structural elements of the E. coli E3, presumably around the FAD binding site 
on each monomer.
All attempts to refold the yeast and bovine E3 after GdnHCI-induced unfolding 
have been unsuccessful as shown in Table 5.2. It is not clear why this is so. although the 
refolding of yeast and bovine E3 may well be possible in vitro under different
conditions. The inclusion of 1 mM DTT wdth FAD in the refolding buffer gave a 62*7
recovery of activity after 180 min as shown in Table 5.1. This suggests that the 
.oxidation state of the refolding buffer is another important factor affecting the yield of 
regained activity and that the chaperone experiments described here may not have been I
carried out under ideal conditions.
:
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